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ABSTRACT
The sleep of high anxiety\worry and low 
anxiety\worry subjects were studied by means of nocturnal 
polysomnography. Fifteen high anxiety adult subjects were 
chosen to represent an analog Generalized Anxiety Disorder 
(GAD) population, and were selected from among individuals 
scoring within the upper 20th percentile on the trait 
portion of the State-Trait Anxiety Inventory (STAI) and 
the Penn State Worry Questionnaire (PSWQ). Fifteen low 
anxiety subjects were selected from among individuals 
scoring within the lower 50th percentile on those 
measures, and were matched with high anxiety subjects for 
age, sex, race, and Beck Depression Inventory (BDI) 
scores. Analysis of polysomnography variables revealed 
that high anxiety subjects took longer to fall asleep, had 
a smaller percentage of deep (slow-wave) sleep, and a 
larger percentage of light transitional sleep (stage 1 
NREM) . High anxiety subjects also had more stage 1 NREM 
periods, more micro-arousals during the first half of the 
sleep period, and a lower REM density relative to low 
anxiety subjects. In addition, high anxiety subjects had 
more electrodermal storming when SWS and REM sleep 
variables were co-varied. Results indicated that the 
pattern of disruption of sleep depth and continuity was 
very similar to that documented in clinical anxiety 
disorder patients, and was distinct from that typically
v
shown in depressed patients. A major implication is that 
anxiety and worry are associated with disrupted sleep, 
independent of whether or not a diagnosed anxiety disorder 
is present. Current results indicate that these factors 
are associated with the sleep disruption observed in 
anxiety disorders, independent of the presence of panic, 
previous exposure to trauma, or a disease process per se.
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INTRODUCTION
Research investigating the inpact of clinical anxiety 
disorders and experimental stress paradigms upon EEG sleep 
profiles suggest a characteristic disturbance of sleep in 
which disruption of the deeper stages of sleep appears to 
be primary. Prior to reviewing this literature, a general 
description of the methods and variables typically 
utilized in the area of sleep research, as well as a brief 
discussion of the general factors influencing sleep 
architecture, will be provided.
Research Procedures and Terminology
Experimental studies of human sleep have 
characteristically used a procedure referred to as 
polysomnography. Polysomnography is an 
electrophysiological recording procedure which utilizes 
three standardized measures to characterize sleep: 
electroencephalography (EEG) , electrooculography (EOG) , 
and electromyography (EMG) . A standardized scoring 
procedure for polysomnography, developed by Rechtschaffen 
and Kales in 1968, has been consistently used for both 
research and clinical purposes. Because the variables 
discussed throughout the sleep literature make reference 
to terms defined by this scoring procedure, a basic 
outline of the scoring system and the definitions of 
standard the terms will be provided. According to this
1
2scoring procedure, sleep stages are delineated primarily 
by EEG characteristics including relative amounts of alpha 
and delta waves, as well as distinctive wave formations 
such as K-complexes and sleep spindles.
A waking EEG is characterized by beta and alpha 
activity. Beta activity, which consists of low voltage, 
irregular, high frequency waves, represents a state of 
arousal and alertness. Alpha is associated with a state 
of relaxed wakefulness, with the eyes closed, and also is 
often present in small amounts during transitional sleep 
(Stage 1 NREM), the lightest stage of sleep. Alpha 
activity is represented by a relatively synchronous, low 
frequency wave (8-12 Hz) of low to moderate voltage.
Delta activity, which is characteristic of the deepest 
most restorative sleep, consists of low frequency (1-4 
Hz), synchronous, high voltage activity (Carlson, 1986). 
Theta activity is not specific to a particular stage of 
sleep and may be seen during stages 1 and 2 NREM and REM 
sleep. It is characterized by low frequency (4 to 7 Hz) 
low to moderate voltage that may be regular or irregular.
In addition to these characteristic wave forms, 
distinctive wave patterns, which include K-complexes and 
sleep spindles, are used in sleep scoring. K-complexes 
are defined as high voltage EEG wave forms having a well 
delineated negative sharp wave which is immediately 
followed by a positive component, with the total duration
3of the complex lasting at least 0.5 seconds (about 3 to 4 
Hz). Sleep spindles are defined by a burst of synchronous 
12-14 Hz activity of low to moderate voltage, and must 
also be of at least a 0.5 second duration (Rechtschaffen & 
Kales, 1968).
In addition to EEG patterns, electrooculographic 
(EOG) and electromyographic (EMG) changes are used to 
define and measure the five stages of sleep (stages 1 - 4  
NREM and stage 1 REM) across a normal night. EOG channels 
provide information about the speed, magnitude and 
direction of eye movements from electrodes placed near the 
outer canthus of each eye. EMG recordings provide 
information regarding the tonicity of muscles on and 
beneath the chin.
These sources of information (EEG, EOG, EMG) are used 
to delineate sleep stages in the following manner. EEG 
recordings immediately prior to sleep onset are 
characterized by a preponderance of alpha activity and/or 
low voltage, mixed frequency EEG activity. Although not 
included within the five sleep stages, this state is 
frequently referred to as Stage W in research literature. 
Stage 1 NREM is characterized by low voltage, mixed 
frequency EEG activity in the 2-7 Hz range in conjunction 
with a relative decrease in alpha (less than 50% of the 
standard measurement period, 30 seconds) and the presence 
of slow movements in the EOG channels. Stage 2 NREM shows
characteristic EEG patterns of K-complexes and sleep 
spindles on a background of relatively low voltage, mixed 
frequency EEG activity, while stages 3 and 4 NREM are 
defined by the occurrence of high voltage low frequency 
delta waves. REM sleep, which is generally associated 
with dreaming, occurs when a stage 1 EEG is present in 
conjunction with markedly decreased EMG activity and the 
occurrence of rapid eye movements in the EOG channels.
Stages 2-4 NREM are collectively referred to as 
synchronous sleep (SS) or NREM sleep by researchers.
These stages are differentiated by visual ratings of the 
amounts of high voltage delta (HVD) activity in each EEG 
epoch: stage 2 NREM contains little HVD (less than 20%) ,
stage 3 NREM an intermediate amount (at least 20% but not
more than 50%), and stage 4 NREM is dominated by HVD
activity (more than 50%) . Stages 3 and 4 NREM are
frequently referred to jointly as slow-wave sleep (SWS) or 
delta sleep.
General Factors Influencing Sleep Architecture
Sleep architecture refers to the orderly progression 
of stages which occur during an ordinary night's sleep.
The five stages of human sleep alternate in a cyclic 
fashion, with periodic episodes of REM sleep occurring at 
approximately 90 minute intervals, and with each 
successive REM episode getting longer. In contrast, SWS
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Figure 1. Polysomnographic recordings illustrating 
wakefulness and sleep stages 1,2,3,4, and REM. Based on 
Rechtschaffen & Kales, (1963) A Manual of Standardized 
Terminology, Techniques, and Scoring System for Sleep 
Stages of Human Sleep Subjects.
episodes becoming successively shorter as the sleep period 
progresses. Thus, SWS is generally confined to the first 
half of the night's sleep, and the majority of REM to the 
second half (Home, 1976) .
Two primary processes have been found to influence 
sleep architecture: circadian rhythmicity and homeostasis 
(Borbely, 1982) . Circadian rhythms refer to the cycles of 
approximately 24 hours which govern the majority of 
physiological functions in the human body. Light appears 
to be the most important factor in synchronizing 
biological cycles, with the suprachiasmatic nucleus of the 
hypothalamus acting as the main oscillator, or biological 
clock, within the system (Hauri, 1992). In the context of 
sleep, homeostasis (the tendency toward stability in the 
normal physiological state of an organism) relates 
primarily to SWS. It is expressed by the preservation of 
deeper stages of sleep in restricted sleep paradigms 
(Home & Wilkinson, 1985/ Tilley & Wilkinson, 1984) and 
the preferential rebound of SWS during recovery sleep 
following sleep restriction (Tilley, Donohoe, & Hensby, 
1987).
The duration of SWS is primarily influenced by the 
length of the prior period of wakefulness. Following 
sleep deprivation, the changes in SWS from baseline levels 
during subsequent recovery sleep has been shown to be 
directly related to outstanding SWS debt (Tilley et al.,
1987) . In fact, the remarkable precision of SWS 
homeostatic control has led researchers to conclude that 
delta sleep is of considerable biological importance 
(Feinberg, March, Floyd, Jimison, Bossom-Demitrack & Katz, 
1985) , though the nature of that function is currently 
uncertain.
In addition to sleep debt, the timing of sleep exerts 
an effect upon sleep architecture through the influence of 
circadian rhythms. A major control variable of the 
circadian system is body temperature, which has been shown 
to drive sleep patterns in the absence of light/dark 
cycles (Czeisler et al, 1980). Sleep onset typically 
occurs as the body temperature falls, beginning in the 
early evening hours (5-7 pm) and temperature continues to 
fall through the mid-morning hours (until 5-7 am) . 
Circadian rhythms appear to exert a particularly strong 
influence upon REM sleep; the majority of REM occurs 
during mid morning hours which constitute the low point in 
the temperature cycle.
In situations where circadian and homeostatic factors 
exert conflicting influences, the impact of homeostatic 
drive is more powerful in determining sleep architecture. 
Although restriction of the sleep period to the first half 
of the night results in large losses of stage 2 and REM 
sleep, with only a relatively small loss of SWS (Tilley & 
Wilkinson, 1984), the response of the sleep system
following this restricted schedule has been found to be 
relatively unaffected by the REM and stage 2 NREM debt, or 
by the timing of the subsequent sleep period. Even when 
recovery sleep occurred during the second half of the 
night, a period in which circadian factors are believed to 
be preferentially conducive to REM sleep, the composition 
of recovery sleep was primarily determined by SWS debt 
(Tilley, 1985).
In conjunction, these findings strongly support the 
hypothesis that obtaining a daily quota of SWS acts as the 
primary drive mechanism of the sleep system. In 
contrast, the overall amount of REM sleep appears to be 
related to the length of the sleep period. When the sleep 
period is extended, absolute amounts of SWS do not 
increase and remain concentrated during the early portion 
of the sleep period; the additional sleep is composed 
primarily of REM and stage 2 (Webb & Agnew, 1970) . It has 
been hypothesized that REM latency is influenced by SWS; 
that REM onset occurs only after a sufficient amount of 
the drive for deeper sleep is satisfied (Home, 1976) .
Functions of Slow-Wave Sleep
Although substantial research exists suggesting the 
importance of obtaining a daily quota of SWS, there is no 
universally accepted theory regarding its purpose.
Several theories of the role of SWS have been proposed; it
has been hypothesized to represent a crucial factor in 
information processing, as well as in cerebral energy 
conservation and physical and mental restitution.
Researchers supporting the role of SWS in information 
processing propose a sequential hypothesis in which the 
information gathered by the brain during the waking period 
is processed during sleep in two main stages, which 
correspond with synchronized sleep (SS; SWS) and REM sleep 
periods. Ambrosini, Sadile, Camevale, Mattiaccio, and 
Giuditta (1987a; 1987b; 1991a; 1991b), in a series of 
studies which investigated the sleep patterns of a group 
of rats following exposure to a learning paradigm, 
conclude that synchronized sleep fulfills a primary role 
in the initial processing of information gathered during 
the preceding waking period. These conclusions were drawn 
from observations indicating that the structure of SS was 
determined by the nature of the previous waking experience 
(rats exposed to a two way active avoidance task vs. 
control rats left in home cages) , with the average 
duration of SS episodes markedly increased in rats exposed 
to the learning paradigm. Rats that effectively learned 
(L) the task were found to differ from non-learning (NL) 
rats in the time of appearance and extent of the 
increments in the average duration of SS episodes followed 
by wakefulness versus SS episodes followed by paradoxical 
(REM) sleep. NL rats showed a greater tendency toward SS-
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W periods, while L rats demonstrated a greater tendency 
toward extended SS periods followed by REM sleep. Based 
upon this information, it was suggested that memory traces 
lacking adaptive value may be cleared away during SS-W and 
SS-REM episodes, while the remaining memory traces may be 
retained and eventually stored again in more integrated 
form during SS-REM and REM episodes, respectively. These 
conclusions are problematic in several ways. The failure 
of these authors to distinguish between high amplitude SS 
(similar to SWS) and lighter stages of NREM sleep limit 
the specificity of their findings and may serve to obscure 
important differences in NREM sleep structure of post- 
acquisition sleep. In addition, it appears that there is 
an important uncontrolled variable, stress, which may be 
reasonably assumed to differ among control, learning, and 
non-learning rats; and which could have influenced sleep 
architecture.
Other basic animal research investigators have 
hypothesized that the decreased levels of mean cerebral 
metabolism, and markedly lowered metabolism in the 
thalamic sensory relays and cortex during SWS, supports a 
role for SWS in cerebral energy conservation (Ramm &
Frost, 1986). Other theorists have expanded the energy 
conservation hypotheses to include restorative functions. 
SWS has traditionally been linked to general tissue 
restitution, primarily as a result of the increased
synthesis and release of human growth hormone which occurs 
during this period (Adams & Oswald, 1977) . However, Home 
(1983/ 1985) reviewed available research regarding SWS and 
general tissue restoration and concluded that there is 
little convincing evidence supporting the role of SWS in 
this process. Rather, he proposed that sleep may actually 
represent a degenerative period due to the night-time 
fast. In the absence of evidence for a general tissue 
restoration hypothesis, it is proposed that SWS more 
accurately represents a period of cerebral restitution.
In both animal and human research, SWS consistently has 
been found to reflect a degree of lowered cerebral 
metabolic activity relative to that found in other states 
of consciousness. In addition, SWS has the appearance of 
some form of recovery function, as it is the sleep state 
most highly correlated with the length of prior 
wakefulness. Home also concludes that only a portion of 
sleep seems obligatory, and that this portion is 
associated with the SWS present during the first few hours 
of the sleep period.
The theory that SWS represents obligatory and 
restorative sleep, which is believed to be oriented 
towards brain restitution, is consistent with evidence 
indicating that obtaining a daily quota of SWS represents 
the primary sleep drive. Other periods of sleep, such as 
REM, represent a less primary drive and are thus
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influenced by other factors such as the timing of the 
sleep period. These secondary sleep functions, which 
include both REM sleep and the lighter stages of NREM 
sleep (stages 1 & 2), are believed by many theorists to 
result from an adaptive, rather than restorative, function 
of sleep (Webb, 1988) . They are proposed to have evolved 
as an adaptive behavioral responses associated with 
predator/predatee and foraging requirements of the 
species.
H o m e 1 s hypothesis that SWS represents a period of 
cerebral restitution does not contradict the possibility 
that SWS is involved in the processing of information 
gathered during the waking period. Thus, although no firm 
consensus exists as to the exact function of SWS, the 
prevailing theories are not inconsistent with one another.
Failure to obtain sufficient amounts of delta sleep 
have been linked to specific decrements in daytime 
cognitive performance of healthy subjects. Partial or 
total sleep deprivation has been shown to produce a 
significant worsening of performance on vigilance and 
reaction time tasks (Bonnet, 1985; 1986b; Downey & Bonnet, 
1987; Home, Anderson, & Wilkinson, 1983; Tilley & 
Wilkinson, 1984) . Home and Wilkinson (1985) attenpted to 
determine if the relationship between cognitive 
performance and sleep parameters was homogenous or if it 
had a specific correlation with a certain sleep parameter.
By reducing the last 2 hours of sleep each night during a 
6 week period they were able to decrease stage 2 and REM, 
while leaving SWS unmodified. Under these conditions no 
deleterious effect upon daytime vigilance was observed. 
Thus, although it seems clear that daytime performance is 
affected by sleep deprivation, this decrement does not 
appear to occur with selective stage 2 NREM or REM sleep 
loss.
In addition, specific decrements in SWS have been 
found to be correlated with slowed reaction times in 
normal subjects. When a group of subjects with slow 
versus fast reaction times were compared on baseline sleep 
EEG measures, subjects with slow reaction times were shown 
to have significantly less delta sleep than subjects with 
fast reaction times (Jurado, Luna-Villegas, & Buela-Casal, 
1989), leading researchers to suggest that attention after 
awakening is related specifically to the amount of delta 
sleep during the night. Healthy young subjects deprived 
of delta sleep by periodic awakenings have also been shown 
to have significant decreases in morning vigilance and nap 
latency (Bonnet, 1987), as well as significant increases 
in subjective ratings of fatigue and decreases in mood 
ratings suggestive of a blunting of emotional responses. 
These subjects reported feeling more unhappy, less 
friendly, less angry, and less clear-thinking following 
SWS deprivation. In summary, considerable research
evidence suggests that SWS represents the primary drive in 
the sleep system; and reduction of SWS has been 
demonstrated to have observable effects on behavior and 
mood during the subsequent waking period. This is of 
particular interest given that disruption of sleep 
architecture and reduction of SWS has been documented to 
occur in the presence of environmental stressors, and to 
constitute a prominent symptom in the clinical 
presentation of many psychiatric disorders.
REVIEW OF LITERATURE 
Inpact of Stress on Sleep Profiles
The effect of various stress paradigms on sleep 
architecture has received some direct research attention 
in both animal and human studies. Experimental designs 
used in these studies have typically differed along two 
continua: whether they involve acute or chronic stress and 
whether they involve physical or psychological stress.
Transient Stressors
The effects of acute situational anxiety on 
polysomnographic measures of human sleep have been 
documented across several experimental situations, with 
mixed findings. The pre-sleep viewing of a stressful 
film has been associated with an increased number of 
arousals from REM sleep and an elevated frequency of REMs 
(REM density) during REM periods. The disruption appeared 
to be specific to REM sleep; neither increased frequency 
of NREM arousals nor disruption or reduction of SWS were 
noted (Baekland, Koulack & Lasky, 1968). However, this 
early evidence of disruption of REM processes by transient 
stressors has not received subsequent research support.
For example, significant changes in sleep parameters 
were not found among eighteen skydivers undergoing the 
voluntary stress of a parachute jump. Neither novice nor 
experienced groups showed disruption of SWS or REM
15
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processes during either the sleep period preceding or 
following the jump, suggesting that the anticipatory 
anxiety and physiological arousal associated with the jump 
did not significantly effect sleep in these individuals 
(Beaumaster, Knowles, & MacLean, 1978) . However, these 
subjects represent a rather unique group in that they 
voluntarily sought the arousal associated with the 
parachute jump, a situation with little similarity to that 
of individuals experiencing clinical anxiety disorders or 
undergoing stressful life events.
Very little sleep research utilizing experimental 
paradigms involving exposure to transient stressors has 
been published, which may be due to the failure of these 
paradigms to produce large enough effects on subsequent 
sleep profiles to reach statistical significance. On the 
other hand, this trend may reflect the difficulty of doing 
ethical research on the effects of transient stressors 
that are of sufficient intensity to produce statistically 
significant differences. However, stronger and more 
consistent effects have been shown in subjects involved in 
ongoing stressful situations.
Ongoing or Chronic Stressors
Significant decreases in slow-wave sleep (in both 
animal and human subjects), as well as disrupted sleep 
continuity, have been documented in experimental paradigms
involving ongoing stressors of a more chronic nature. 
Decreases in slow-wave sleep (specifically stage 4 sleep) 
have been documented in a sample of medical students 
undergoing exams (Lester, Burch, & Dossett, 1967). In 
this investigation, 53 healthy subjects spent 10 nights in 
the sleep laboratory. During this 10 day period, sleep 
was measured for 3 consecutive nights surrounding 2 
independent events (1) a laboratory manipulation designed 
to represent a mild acute stressor and (2) a day of 
medical exams. In addition, throughout data acquisition 
subjects were interviewed regarding significant events 
during the preceding day. Thus, days containing 
fortuitous real-life stress events were identified. These 
real-life stressors and the time period surrounding 
medical school exams were associated with the highest 
level of self-reported anxiety among subjects, and subject 
sleep profiles indicated a decrease in the percentage of 
stage 4 NREM sleep and an overall increase in awakenings 
as self-reported daytime stress increased. In addition, 
anecdotal information gathered during data acquisition 
suggested that subjects undergoing stressors in their 
personal lives, which were of a more severe and chronic 
nature than those represented by exams or the experimental 
manipulation, showed a more severe disruption of sleep EEG 
patterns, which was characterized by a complete absence of 
SWS. However, no significant effect on sleep parameters
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were found for the time period surrounding the laboratory 
stressor, and the percentage of stage REM sleep showed no 
systematic relationship to self-reported stress in any of 
the experimental conditions.
Disruption of sleep parameters, most notably SWS 
processes and sleep continuity, also has been observed 
among both animal and human populations during periods of 
ongoing physical and psychological stress. The effects of 
chronic pain on sleep in the rat were investigated by 
Landis, Levine, and Robinson, 1989. The chronic pain 
condition, which involved adjuvant arthritis, was found to 
result in an increased sleep latency as well as general 
increases in the percentage of time spent awake and in 
light sleep. In addition, a significant decrease from 
baseline in the amount of high amplitude NREM sleep (SWS) 
was noted in animals following initiation of the chronic 
pain condition. Decreases in the amount of time spent in 
deep SWS have also been documented in animal models of 
chronic anxiety (Marczynski & Urbancic, 1988). Rats that 
underwent prenatal exposure to diazepam, which produced 
enduring postnatal deficits of brain benzodiazepine 
receptors, showed both a reduction of time spent in SWS 
and an inability to habituate to novel environments such 
as the radial arm maze. The behavior of "high anxiety" 
rats in the maze was characterized by numerous fecal 
deposits and more frequent than normal errors in working
19
memory, factors which are attributed to increased anxiety 
secondary to decreased benzodiazepine receptors. Although 
these behaviors within the maze environment suggest the 
presence of an animal model of anxiety, the observed 
decrements in SWS among "high anxiety" rats may actually 
represent a non-specific effect of the experimental 
manipulation upon GABA systems associated with SWS, rather 
than an "anxiety" effect.
Severe disruption of SWS processes have also been 
documented in human populations who have undergone cardiac 
surgery. These patients, who were considered to be 
undergoing extreme physical and psychological stress, 
displayed a nearly complete suppression of EEG indications 
of sleep until the second post-operative night (Anch, Orr, 
& Karacan, 1976) . As recovery progressed, SWS remained 
suppressed longer than REM sleep. This pattern appears 
particularly noteworthy given the preeminence of the 
homeostatic drive for SWS, which would predict a 
preferential rebound effect for lost SWS (Tilley et al.,
1987). Problematic confounds exist in interpreting data 
obtained from this population of critically ill hospital 
patients. For example, it is not clear to what extent 
these research subjects were receiving medications, such 
as benzodiazepines, which may have contributed to the 
suppression of SWS. In addition, "recovery" of these 
patients is not clearly defined. Physical recovery may
20
have progressed, but investigators did not document 
psychological recovery. Patient stress levels may have 
remained quite high, thereby contributing to the continued 
suppression of SWS.
Acute Physical and Sensory Stressors
In contrast to findings regarding chronic anxiety or 
physical stressors, experimental manipulations involving 
acute physical or sensory stressors have resulted in 
increased duration of SWS during the sleep period 
following the stressor, and increased stability of SWS 
processes as reflected by a decreased number of stage 
changes. Subjects who were exposed to an acute sensory 
stress in the form of increased daytime noise load showed 
increases in amount of SWS and in stage 4 NREM stability 
during the subsequent nights sleep (Fruhstorfer, 
Fruhstorfer, & Grass, 1984; Fruhstorfer, Fruhstorfer, 
Grass, Milerski, Sturm, Weismann, & Wiesel 1985; 
Fruhstorfer, Pritsch, & Fruhstorfer, 1988). These authors 
interpreted increases in SWS as indicative of an 
intensified need for recovery caused by increased central 
nervous system strain during waking.
The effects of acute physical stressors appear to be 
similar to those of sensory stressors. Physical stress in 
the form of extreme physical exercise has been reported to 
enhance subsequent SWS among physically fit subjects.
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When the sleep of athletes completing a 92-km marathon was 
measured on 4 successive nights, significant increases in 
total sleep time and slow-wave sleep were found during the 
three nights following the race, with the most profound 
increase in stage 4 NREM sleep occurring during the sleep 
period immediately following the event (Shapiro, Bortz, 
Mitchell, Bartel, & Jooste, 1981).
Increases in NREM sleep were also observed during an 
experiment designed to measure of the effect of an acute 
physical stressor on the sleep of infants (Emde, Harmon, 
Metcalf, Koenig, & Wagonfeld, 1971). These authors 
investigated the effect of routine circumcision on 
subsequent sleep. Circumcisions, which were performed 
without anesthesia in a newborn nursery, were typically 
followed by a prolonged NREM sleep period. A group of 
circumcised infants showed increases in NREM sleep from 
pre-operative baseline levels, which ranged from 41 to 
121%, during the night following the operation. A control 
group of infants, monitored during this same time period, 
failed show similar changes from baseline recordings.
Post-circumcision effects on NREM sleep were also 
reflected in a shorter latency to the first NREM period, 
an increased number of NREM periods, and an increased 
number of extended NREM periods. These authors interpret 
this increased tendency toward NREM sleep as fulfilling a
22
drive for conservation/withdrawal following exposure to an 
acute stressor.
Summary of the Effect of Stress Paradigms upon SWS
When stress is viewed as a broad unitary construct, 
overall findings for its effect upon SWS appear somewhat 
weak and inconsistent. However, when stressors are 
categorized along an acute vs. chronic continuum, a more 
cohesive pattern is evident. In general, acute physical 
or sensory stressors appear to be followed by an increased 
tendency toward SWS, while ongoing, chronic physical or 
psychological stress (anxiety) is associated with 
disrupted SWS. Thus, individuals with psychiatric 
disorders entailing emotional stress may be viewed as 
experiencing chronic psychological stress, and would 
therefore be expected to experience more consistent 
disruption of sleep processes than individuals exposed to 
transient stressors.
Polysomnography Profiles of Psychiatric Patients
Disruption of sleep architecture is a robust research 
finding for many psychiatric patient populations. 
Historically, it is the sleep of patients with affective 
disorders that has received the primary focus of research 
attention. Several abnormalities consistently have been 
documented in this population, including decreased sleep
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continuity, diminished SWS, and altered REM sleep.
Altered REM sleep findings include shortened latency to 
the first REM period, increased amount of REM sleep early 
in the night, and increased REM density relative to 
matched controls (Benca, Obermeyer, Thisted, & Gillin, 
1992; Mendlewicz & Kerkhofs, 1991; Reynolds & Kupfer,
1987). Of these REM abnormalities, increased REM density 
appears to be the most consistent finding among depressed 
populations across age ranges (Lauer, Riemann, Wiegand, & 
Berber, 1991)
In contrast to the attention focused on sleep in 
affective disorder populations, very little research has 
been focused on sleep disturbances in anxiety disorder 
patients. When available research is considered, the most 
consistent findings across anxiety disorder groups are 
disturbed sleep continuity and reduced SWS. However, 
these findings lack specificity and are often noted in 
other psychiatric disorders as well, including depression, 
schizophrenia, alcoholism, dementia, and insomnia (Benca 
et al., 1992).
With the publication of the revised edition of the 
diagnostic criteria by the American Psychiatric 
Association in 1980 (DSM-III) and 1987 (DSM-III-R) anxiety 
disorders have been recognized as independent from 
depression, and have received increasing research 
attention. Recent research investigating sleep
disturbances in anxiety disorder patients has focused on 
delineating characteristic sleep profiles of individuals 
with clinical anxiety disorders such as Post-Traumatic 
Stress Disorder (PTSD), Panic Disorder (PD), and 
Generalized Anxiety Disorder (GAD). In addition, there 
has been a recent increase in interest in EEG sleep 
parameters as promising biological markers for 
differentiating primary anxiety vs. depressive 
disturbances, and in determining the viability of an 
independent diagnostic category of mixed anxiety and 
depression (Akiskal, Lemmi, Dickson, King, Yerevanian, &
Van Valkenberg, 1984; Benca et al., 1992). A summary of
available research investigating sleep EEG profiles in 
anxiety disorder patients will now be provided.
Post-Traumatic Stress Disorder
Sleep disturbance in individuals diagnosed with PTSD 
represents the most robust research findings pertaining to 
sleep in the anxiety disorders. Typical sleep EEG 
findings for individuals with PTSD include decreased sleep 
efficiency (decreased proportion of time asleep while in 
bed; increased sleep latency plus time awake after sleep 
onset), increased frequency of awakenings, decreased
amounts of deep restorative sleep (slow wave sleep), 
increased amounts of light transitional sleep (stage 1 
NREM), increased REM latency, and increased indices of
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autonomic arousal and motor activity (Astrom, Lunde, 
Ortmann, Boysen, & Trojaborg, 1989; Glaubman, Mikulincer, 
Porat, Wasserman, & Birger, 1990; Kramer & Kinney, 1988; 
Mellman, Kulich-Bell, Kumar, & Nolan, 1993; van Kammen, 
Christiansen, van Kammen, & Reynolds, 1990). Individuals 
with PTSD also frequently report the reexperiencing of 
traumatic situations in the form of trauma related dreams. 
These dreams are unusual in the fact that they occur in 
the early portion of the sleep period during non-REM sleep 
and are accompanied by great autonomic arousal (Kramer & 
Kinney, 1988; van der Kolk, Blitz, Burr, Winthrop, & 
Sherry, 1984). In addition, individuals with PTSD have 
been found to show an atypical pattern of nocturnal 
arousals: There is an increased tendency toward arousal
during the early portion of the sleep period, a time that 
is normally characterized by deeper stages of sleep and 
decreased tendency for arousal among control subjects 
(Fuller, Waters & Scott, 1993; Kramer & Kinney, 1988).
Panic Disorder
The available sleep data from individuals diagnosed 
with panic disorder is sparse and is plagued by 
methodological confounds which limit its value in 
clarifying the nature of sleep disturbances specific to 
anxiety. In particular, a high incidence of comorbid
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depressive disorders exists in many of the subjects used 
in investigations of sleep in panic disorder (PD).
Individuals with PD but without concomitant 
depression have not been found to differ consistently from 
normal controls on measures of sleep architecture or 
continuity (Dube, Jones, Bell, Davies, Ross & Sitram,
1985) . In studies which have found significant 
differences, lower sleep efficiency (as reflected by 
increased sleep onset latency plus decreased total sleep 
time) has been noted in comparison to normal controls 
(Mellman & Uhde, 1989). However, methodological problems 
limit the usefulness of this data: In the study by
Mellman and Uhde (1989), eight of the twelve PD patients 
reported a previous history of major depression, and six 
reported significant depression at the time of the 
investigation.
Sleep EEG data from a relatively homogenous sairple of 
nine individuals diagnosed as PD with agoraphobia, who 
were free from depressive synptoms at the time of 
polysomnography, demonstrated increased movement time, 
decreased REM latency, and reduced REM density relative to 
normal controls (Uhde, Roy-Byrne, Gillin, Mendelson, 
Boulenger, Wittone, & Post, 1984). However, observed REM 
latencies were twice the length typically reported in 
affective disorder sairples, and were not statistically 
different from previously published age norms (Williams et
al., 1974). Additional data obtained from patients 
participating in the study by Uhde and colleagues 
indicated significant negative correlations between 
measures of global anxiety with both total sleep time and 
REM percentage. In addition, the frequency of panic 
attacks was found to be negatively correlated with 
percentage of SWS. Thus, patients with the highest self- 
report of global anxiety reported the most frequent panic 
attacks and had the shortest total sleep time and lowest 
percentages of SWS and REM sleep.
A recent investigation (Stein, Enns, & Kryger, 1993) 
sought to alleviate the problematic confounds of co­
morbidity with depressive disorders and lack of adequate 
control populations. These researchers compared the sleep 
of sixteen patients with PD, who did not currently meet 
criteria for major depression, to sixteen, healthy, age 
matched, control subjects. PD patients showed a moderate 
reduction in total sleep time and delta sleep relative to 
controls, as well as an increased number of stage 1 NREM 
episodes. In addition, a significant negative correlation 
was observed between Speilberger Trait anxiety scores and 
percentage of SWS. No other measures of anxiety or 
depression correlated significantly with any other sleep 
parameter, including any of the measures of sleep 
continuity.
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Characteristic sleep patterns have been noted among 
individuals who experience nocturnal panic attacks. These 
nocturnal attacks have been found to be relatively 
prevalent, with 71% of non-hospitalized PD patients 
reporting their occurrence (Roy-Byrne, Mellman, & Uhde,
1988). Nocturnal panic attacks have been demonstrated to 
occur during non-REM sleep and to be associated with 
markedly increased autonomic arousal. In addition, a 
tendency toward increased REM latencies has been 
documented on nights in which panic occurs (Mellman &
Uhde, 1989).
The frequency of co-morbid depression among 
individuals with PD has led some researchers to include 
"mixed" groups of PD and depressed individuals (Granhaus, 
Rabin, Harel, Greden, Feinberg, & Herman, 1986). Subjects 
with both PD and depression were found to show increased 
time to sleep onset as well as disrupted sleep continuity 
and decreased sleep efficiency relative to individuals 
with only depressive symptoms. In addition, individuals 
in this mixed group have been found to demonstrate REM 
latency times which are significantly longer than those 
shown by groups diagnosed as major depression without 
concomitant anxiety disturbances, and are not 
significantly different from REM latency times among 
normal individuals (Grundhaus et al., 1986).
Given the current lack of a specific knowledge base 
regarding the effect of pure anxiety disorders on sleep 
profiles, inclusion of this "mixed" grouping appears 
somewhat premature. Mixed samples have been found to have 
a longer duration of illness, increased severity of 
symptoms, increased impairment of functioning, and a 
higher incidence of co-morbid psychopathology (Dube,
Jones, Bell, Davies, Ross, & Sitaram, 1985), thus 
suggesting that differences among mixed groups may 
actually represent other non-specific factors.
Generalized Anxiety Disorder
As recently as 1983 a paucity of sleep data existed 
on the complaint of generalized anxiety (Rosa, Bonnet, & 
Kramer, 1983), reflecting its residual status prior to the 
recent publication of DSM-III-R. Recent studies 
addressing sleep EEG findings among psychiatric patients 
diagnosed with generalized anxiety disorder (GAD) have 
typically conpared these subjects to patient groups with 
affective disturbances such as dysthymia or major 
depression and/or normal control subjects.
A recent study which investigated sleep patterns 
among psychiatric outpatients with the DSM-III-R diagnosis 
of GAD found these individuals to have decreased sleep 
efficiency, decreased percentage of SWS, and increased 
awake time after sleep onset relative to healthy controls
(Arriaga & Paiva, 1990). However, when patients with GAD 
were compared with patients diagnosed with primary 
dysthymia, they did not consistently differ on measures of 
SWS. Anxious subjects were found to differ from dysthymic 
subjects in that they had less total sleep time and showed 
a predominance of awakenings and stage 2 NREM sleep 
following initial sleep onset. Thus, the authors 
concluded that although overall reduction of SWS lacked 
specificity, it appeared to have different 
physiopathologic significance in these two psychiatric 
groups: Among subjects with GAD it seemed to represent an
epiphenomenon resulting from reduction and fragmentation 
of sleep, while it was not associated with similar 
features of insomnia among dysthymic subjects.
In an uncontrolled investigation which compared 
outpatients diagnosed with GAD versus major depressive 
disorder (MDD) (Reynolds, Shaw, Newton, Coble, & Kupfer, 
1983), both psychiatric groups demonstrated a pattern of 
disrupted sleep when corrpared to previously published age 
norms (Williams, Karacan & Hursch, 1974) . Both sets of 
subjects showed decreased percentage of SWS and decreased 
sleep efficiency, as well as problems initiating and 
maintaining sleep which were evidenced by an increased 
number of awakenings and increased sleep onset latency. 
When compared directly to individuals with major 
depression, GAD subjects were found to experience an
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increased amount of intermittent wakefulness, increased 
REM latency, and decreased REM percentage and density; 
measures of SWS and sleep continuity were not found to 
differ between groups. However, the usefulness of the 
results from this investigation is limited by poor subject 
selection: Individuals in the anxious group were also
significantly depressed, and six of the ten anxious 
subjects also had concomitant personality or affective 
disorders. This prevalence of co-morbidity among the 
anxiety subjects limits the extent to which observed 
polysomnography profiles may be considered to reflect 
specific anxiety processes.
Similar results were obtained when a group of 
inpatients with GAD were compared with inpatients with MDD 
and normal control subjects. GAD patients were found to 
have increased sleep latency and decreased total sleep 
time relative to control subjects (Papadimitriou,
Kerkhofs, Kempenaers, & Mendlewicz, 1988). In addition, 
these GAD subjects showed significantly longer REM latency 
and lower percentage of REM sleep than MDD subjects. 
However, contrary to other published research findings 
(Arriaga & Paiva, 1990; Reynolds et al., 1983), this 
sample of GAD patients showed fewer awakenings during the 
sleep period than MDD subjects. Although differences were 
not statistically significant, GAD subjects did show a
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lower mean percentage of SWS relative to both MDD and 
control groups.
When GAD subjects were compared with a mixed subject
group diagnosed with both MDD and GAD, as well as subjects
with MDD without concomitant anxiety (Papadimitriou, 
Linkowski, Kerkhofs, Kempenaers, & Mendlewicz, 1988); no 
significant differences in sleep EEG were found between 
the mixed group and the GAD group. The mixed group showed 
longer REM latency than the MDD group, with values falling 
close to those of GAD patients. No differences were noted 
in percentage of SWS or other measures of sleep
architecture between groups. However, no control group
was available for comparison.
Mixed Anxiety and Depression
In addition to differences noted in individuals with 
clinical anxiety disorders, differences in EEG sleep 
profiles have been noted among affective disorder patients 
as a function of anxiety level (Akiskal, Lemmi, Dickson, 
King, Yerevanian, & van Valkenburg, 1984) . A group of 
dysthymic patients with concomitant "anxiety neurosis" 
showed significant differences in sleep variables when 
compared to general dysthymic patients and a control group 
of medically ill patients. Subjects in the anxious 
dysthymic group included individuals with generalized 
anxiety disorder and/or panic disorder in conjunction with
chronic dysphoric syrrptoms. Insomnia was found to be a 
prominent presenting complaint among the anxious 
dysthymics, while "pure" dysthymics reported a high 
incidence of hypersomnia. In addition, anxious 
depressives showed higher degrees of arousal as measured 
by a greater number of awakenings and stage shifts than 
the other two groups, while dysthymics showed 
significantly decreased REM latency.
A recent investigation sought to clarify the effect 
of situational anxiety on the sleep of depressed 
individuals by examining the effect of severe stress on 
the polysomnography profiles of individuals with the 
diagnosis of endogenous MDD without co-morbid anxiety 
disorders (Monroe, Simmons, & Thase, 1992). Persons who 
had experienced severe stressors shortly before the onset 
of depression were found to have essentially normal REM 
latency values, while patients without such stress showed 
reduced REM latency values. When the effects of severe 
events were statistically removed, and the influence of 
increased "life stress" both before and after onset of 
depression was assessed, the relationship continued to 
hold: Individuals with high stress levels showed
essentially normal REM latency values. This data supports 
a hypothesis that stress may influence REM latency through 
mechanisms other than those which are thought to determine 
etiologic differences. The authors suggest that life
stress prolongs REM latency, thereby approximating normal 
values among depressed individuals who would theoretically 
have abnormally short REM latencies. Unfortunately, 
reporting of sleep EEG findings in this study was confined 
to REM latency values, thus limiting the usefulness of 
results in determining the possible mechanism(s) by which 
stressors extend REM latency times. In addition, no 
control group of non-depressed individuals was available 
for comparison, thus leaving the effect of increased life 
stress upon REM latency in individuals without depressive 
disorders unclear.
Summary of Psychiatric Findings
In summary, polysomnographic findings across anxiety 
populations have been somewhat less consistent than 
results obtained from individuals diagnosed with 
endogenous depression. General findings include decreased 
SWS and increased REM latency, as well as decreases in 
total sleep time, sleep efficiency, and sleep continuity 
measures. Although overall reduction of SWS and 
disruption of sleep continuity have not been shown to be 
specific to anxiety disorder populations, multiple 
research findings suggest that the total amount of SWS, as 
well as sleep continuity and duration, are correlated with 
measures of clinical severity in anxiety populations, but 
are not similarly correlated in affective disorder
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populations (Arriaga, Rosado, & Paiva, 1990; Mellman, 
Thomas, & Uhde, 1989; Papdimitrou, Linkowsky, & Kerkhofs,
1988) .
The relation between anxiety and the disruption of 
SWS and sleep continuity is further strengthened by- 
research findings among non-psychiatric individuals with 
high levels of generalized anxiety. When depression was 
held statistically constant in this population, a 
significant positive relationship was noted between 
anxiety ratings and number of awakenings, and a 
significant negative correlation was found between level 
of anxiety and amount of SWS (Rosa et al., 1983) . In 
contrast, significant correlations were not present 
between these sleep parameters and depression ratings.
In addition, these high anxiety individuals showed 
disruptions of sleep similar to those documented in 
clinical anxiety disorders, with a marked tendency toward 
less sleep and lighter sleep.
Additional evidence suggesting that a specific 
disruption of sleep continuity is characteristic of 
anxiety populations is provided by findings of an atypical 
arousal pattern among individuals with PTSD. However, 
this phenomenon has not been investigated in other anxiety 
disorder groups, and it is unclear to what extent it may 
be limited specifically to individuals previously exposed 
to traumatic situations. In addition, no formal scoring
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criteria for arousals or awakenings was available prior to 
the standards published in 1992 (Bonnet et al., 1992), and 
this lack of methodological consistency limits the 
reliability of previous research results.
The area of polysomnographic research among anxiety 
disorder populations contains several other problematic 
confounds, including the frequent presence of co-morbid 
pathology in anxiety disorder populations (Sanderson, 
DiNardo, Rapee, & Barlow, 1990) and the long-standing 
nature of the psychiatric disturbance in many such 
research subjects (Akiskal et al., 1984; Reynolds et al., 
1983). These factors call into question the assumption 
that it is primarily the anxiety level of the subjects 
which accounts for polysomnographic changes noted among 
these clinical groups, and necessitate further research on 
individuals with "pure" anxiety states which are not 
complicated by comorbid psychopathology.
THE PRESENT STUDY 
Population of Interest
The purpose of the investigation was to clarify the 
nature of sleep disturbance associated with "pure" anxiety 
states. In order to investigate the inpact of anxiety 
levels on sleep in individuals without concomitant 
psychopathology, a sanple of individuals with an analogue 
of generalized anxiety disorder (GAD) was selected from 
among undergraduate students at Louisiana State 
University. Generalized Anxiety Disorder has been 
characterized as a relatively pure instance of high trait 
anxiety (Rapee, 1991). Age of onset is generally early 
and insidious, many individuals report the disorder as 
lifelong (Rapee, 1985). It has been characterized as the 
most "normal" anxiety disorder, and it is virtually 
inpossible to define a cutoff point quantitatively 
distinguishing GAD from normal anxiety (Hoehn-Saric & 
MacLeod, 1992). There does not appear to be a clear 
qualitative demarcation distinguishing GADs from non­
psychiatric populations with high levels of trait anxiety. 
In fact, cognitive differences between GAD subjects and 
normals have been found to be much the same as between 
normals who are high and normals who are low on measures 
of trait anxiety (Eysenck & Mathews, 1987) . The tendency 
to worry, which is the central feature of GAD as defined 
by DSM-III-R, also has been found to be highly correlated
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with trait anxiety (Borkovec, Robinson, Pruzinske, & 
Depree, 1983). In light of the similarities between 
individuals with high trait anxiety and those with GAD, an 
analog population of individuals with high trait anxiety 
was chosen as one that could be appropriately compared to 
normal individuals with low trait anxiety.
There is typically a long time between the onset of 
GAD (mid-teens) and presentation to a clinical facility, 
with an average period of almost 25 years (Rapee, 1991). 
During this time there is ample opportunity for the 
development of secondary psychopathology, such as 
depression, as a consequence of demoralization resulting 
from chronic anxiety (Akiskal et al., 1984; Barlow, 1992) . 
Thus, by identifying a relatively young subject pool high 
in trait anxiety prior to their presentation to a clinical 
facility it was hoped that the confounding co-morbidity 
present in the psychiatric literature would be avoided.
The trait portion of the State-Trait Anxiety 
Inventory (STAI Appendix A) and the Penn State Worry 
Questionnaire (PSWQ Appendix B) were used a screening 
measures to identify this subject pool. The STAI is a 
frequently used, brief, self-report measure of state and 
trait anxiety which has been shown to be of adequate 
reliability and validity. Alpha coefficients for the 
trait anxiety component of the instrument range from .90 
to .92 (Speilberger, 1983). Items for the trait portion
of the scale, which was utilized in the present 
investigation, were originally selected because they were 
highly correlated with the Manifest Anxiety Scale (Taylor, 
1951), were stable over time, and were not much affected 
by situational stress (Taylor & Amow, 1988) . In general, 
the assumptions of the STAI have been confirmed. The 
STAI-state has been shown to be influenced by situational 
factors, while the STAI-trait has shown stable properties. 
STAI-trait test-retest reliability coefficients have been 
found to range from .76 to .86 across a 20 day delay 
(Speilberger, 1983).
The second selection instrument, the PSWQ (Appendix 
B), is a recently developed, brief self-report measure 
which has been shown to possess high internal consistency 
(alpha coefficient = .94) and a test-retest reliability 
coefficient of .92 (Meyer, Miller, Metzger, & Borkovec, 
1990). The measure has also been shown to be stable over 
periods of 2 weeks (r = .75) and 4 weeks (r = .74), and to 
significantly discriminate college satrples who met all, 
some, or none of the DSM-III-R criteria for generalized 
anxiety disorder. The PSWQ has also shown discriminant 
validity in that it successfully identified GAD from all 
other anxiety disorders (Brown, Antony, & Barlow, 1992).
These two selection measures were chosen for their 
relative brevity and sensitivity to factors associated 
with GAD. The STAI-trait was included due to its
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widespread use as a research tool and its previous success 
in differentiating college samples into high versus low 
trait anxiety samples. Subjects selected by virtue of 
STAI-trait scores have shown significant differences in 
self-reported sleep patterns as well as measures of whole 
blood serotonin content (Davis, Dunlop, Shea, Brittain, & 
Hendrie, 1985). The PSWQ was included for its emphasis on 
cognitive factors associated with GAD. With the advent of 
DSM-III-R, etrphasis of diagnostic criteria for GAD has 
shifted toward the cognitive component of the disorder, 
worry. Current trends also suggest that pathological 
worry (worry perceived as uncontrollable) will become an 
essential feature of the DSM-IV criteria (Barlow & 
DiNardo, 1991). Thus, it was anticipated that through 
inclusion of these two measures, a sample would be 
identified with the characteristics of high trait anxiety, 
as defined in previous research, as well as the cognitive 
conponent (worry) which most reliably distinguishes GAD as 
a diagnostic entity apart from other anxiety disorders.
High anxiety subjects were chosen from among 
individuals scoring within the top 20th percentile of the 
screening sample on both the STAI-trait and PSWQ; low 
anxiety subjects were chosen from among individuals 
scoring within the bottom 50th percentile on these 
measures.
Subjects were also administered the Beck Depression 
Inventory (BDI Appendix C; Beck, 1978; Beck, Ward, 
Mendelson, Mock & Erbaugh, 1961) during initial screening 
procedures. The BDI is the most frequently used self- 
report method for assessing level of depression (Shaw, 
Vallis, Sc McCabe, 1985) . It has been shown to have 
adequate internal consistency (Beck & Steer, 1987;
Reynolds & Gould, 1981), with alpha coefficients of .86 
and .81 for psychiatric and non-psychiatric populations, 
respectively. The BDI has also been shown to have 
concurrent validity with clinician's ratings of depression 
(Beck et al., 1961; Brumberry, Oliver, & McClure, 1978). 
Subjects within the high and low anxiety groups were 
matched for BDI score (within 2 points) in order to avoid 
a difference in level of depression between groups. In 
addition, any subject scoring a BDI of 15 or higher was 
excluded from further participation, as this level has 
been reported to be indicative of clinically significant 
depressive synptoms (Beck & Steer, 1987).
After reading and signing a General Informed Consent 
(Appendix D) subjects were also screened orally to rule 
out the presence several psychiatric disorders which have 
been found to affect sleep, including panic disorder,
PTSD, obsessive conpulsive disorder, major depression, 
dysthymia, mania/hypomania, psychosis, and substance 
abuse. The format for this oral screening (Appendix E)
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was based on DSM-III-R diagnostic criteria. The purpose 
of the screening was not formal diagnosis, but to identify 
and exclude subjects who may have met diagnostic criteria 
for previously listed psychiatric disorders. Thus, 
subjects were excluded if they reported significant 
psychiatric symptoms, even if sufficient information was 
not present to formulate a definite diagnosis.
Any subjects who reported significant symptoms 
suggestive of psychiatric disorders other than GAD were 
excluded from further participation. Subjects were also 
screened for the presence of confounding sleep 
disturbances by means of the Sleep Disorders Inventory 
(SDI; Appendix F) . Subjects were excluded who endorsed 
items consistent with the presence of sleep apnea, 
periodic limb movements of sleep, restless leg syndrome, 
or various parasomnias (e.g. sleep walking). Subjects who 
reported relying upon alcohol or hypnotic medications to 
fall or stay asleep and individuals with irregular sleep- 
wake cycles (eg. shift workers) were also excluded from 
participation. Other exclusion criteria included previous 
history of psychiatric treatment and regular use of 
illegal drugs or prescription medications known to affect 
sleep.
Variables of Interest
Measures of sleep architecture and quality, including 
sleep onset latency, REM latency, percentage REM,
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percentage Stage 1 NREM, percentage SWS, total stage 
changes, and time awake after sleep onset were of interest 
to the present investigation High anxiety individuals 
were expected to show greater disruption of sleep 
continuity, increased sleep latencies, more light 
transitional sleep, and reduction of SWS.
In addition to these traditional sleep parameters, 
micro-arousals (spontaneous transient arousals) during the 
first and second halves of the sleep period, number of 
stage 1 NREM episodes, and electrodermal activity during 
sleep were assessed in an attempt to maximize the 
sensitivity of polysomnographic recordings. Current 
researchers encourage the study of sleep micro-structure 
to increase the discriminative power of sleep EEG findings 
(Arriaga & Paiva, 1990), and it was hoped that inclusion 
of these additional parameters would aid in clarifying the 
nature of SWS attenuation and sleep continuity disturbance 
previously documented among anxiety subjects.
In addition, prior research has lacked 
standardization of scoring for arousals. The present 
study utilized recently published standardized criteria 
for arousals (Bonnet et al., 1992) to provide a more 
reliable index of these events. These micro-arousals are 
of considerable clinical importance, and have been shown 
to be equally as disruptive of sleep quality and 
restorativeness as full awakenings or movement arousals.
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Periodic micro-arousals have been linked to suppression of 
SWS, as well as degraded mood, increased sleepiness, and 
decline of performance on vigilance tasks during the 
subsequent waking period (Bonnet, 1985; 1986a; 1986b;
1987) .
It was also hypothesized that individuals with high 
trait anxiety would show an atypical arousal pattern 
similar to that evidenced in PTSD subjects, which is 
characterized by a relatively greater number of arousals 
during the first half of the sleep period than is seen in 
normal control subjects. In individuals with normal sleep 
patterns, spontaneous awakenings from sleep are 
hypothesized to reflect the rising phase in the underlying 
circadian rhythm during the sleep period (Gillberg & 
Akerstedt, 1983) . Early portions of the nocturnal sleep 
period are associated with a rapid cooling of the body's 
core temperature, a phenomenon which is correlated with 
high probability of sleep onset, sleep maintenance, and. 
the presence of SWS. As the core temperature rises during 
the latest portions of the nocturnal sleep period, the 
probability of arousal becomes much greater and the 
likelihood of sleep onset and sleep maintenance is 
reduced, even in conditions of sleep deprivation (Gillberg 
& Akerstedt, 1983; Webb, 1982). Thus, spontaneous 
arousals tend to occur predominantly during the second 
half of the night1s sleep while circadian factors are more
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favorable to awakenings and the lighter stages of sleep 
are more prevalent.
Data from previous research investigations (Fuller et 
al., 1993; Kramer & Kinney, 1988) have demonstrated a 
pattern of arousals in control subjects which is 
consistent with this model, and an arousal pattern among 
PTSD subjects which is not. In contrast to control 
subjects, who show the expected decreased arousability 
during the early portion of the sleep period, individuals 
with PTSD show a constant pattern of arousability across 
the sleep period, with significantly greater amounts of 
disruption during the early portions of the night's sleep.
Kramer and Kinney (1988) proposed that individuals who 
have experienced universal trauma, and who are 
experiencing acute symptoms, thereafter maintain an 
altered physiology which is reflected in a disrupted sleep 
rhythm characterized by inappropriately high levels of ANS 
activity during the early portion of the night's sleep, 
with resulting interruption of SWS processes. It was of 
interest whether this pattern is specific to individuals 
who have been exposed to traumatic stimuli and have 
subsequently developed PTSD, or whether a similar pattern 
of arousals would be observed among non-psychiatric 
subjects with high levels of generalized anxiety.
The number of Stage 1 NREM episodes was also of 
interest as a measure of sleep continuity and quality.
Brief episodes of Stage 1 NREM appear to reflect decreased 
continuity of sleep because they are transitional in 
nature and subjects are easily awakened during these 
periods. Because Stage 1 NREM episodes may be very brief 
in nature, their relative number is not necessarily 
reflected in total Stage 1 NREM percentage (Stein et al, 
1993) .
In addition, electrodermal measures were used to 
determine whether there was a greater tendency towards 
periods of excessive electrodermal activity (EDA) in 
highly anxious subjects. Previous research examining all 
night recordings of electrodermal responses have suggested 
an increased tendency toward EDA during SWS and decreased 
EDA during REM sleep (Koumans, Tursky, & Solomon, 1968) . 
These periods of increased spontaneous electrodermal 
activity are referred to as electrodermal "storming." 
Storming rates have been found to be associated with 
spontaneous EDA response rates during waking, which have 
been associated with level of anxiety (Taylor & Arnow,
1988). Storming also appears to be associated with 
presleep trait variables: For exanple, individuals with
high levels of storming have been shown to score higher on 
MMPI measures of anxiety and lower on measures of ego 
strength than individuals with less nocturnal storming 
(McDonald, Shallenberger, Koresko, & Kinzy, 1976).
This phenomenon has also been associated with 
increased situational anxiety in a group of medical 
students studied by Lester et al. (1967). These subjects 
showed a disruption of sleep architecture during periods 
of increased daytime stress, characterized by increased 
awakenings and decreased SWS. In addition, subjects 
showed elevations of electrodermal activity during periods 
of situational stress. Electrodermal activity, which is 
primarily a SWS phenomenon under normal conditions, 
increased in all EEG stages as daytime stress increased.
In contrast, subjects undergoing extreme stressors, who 
showed suppression of SWS sleep, showed decreased 
electrodermal activity from baseline conditions; thus 
suggesting that SWS in a necessary condition for notable 
electrodermal activity in the sleeping state. It was of 
interest to the present investigation whether high levels 
of trait anxiety were associated with elevations of 
storming activity similar to those observed during periods 
of situational stress.
Summary and Hypotheses
In summary, the following polysomnography variables 
were investigated in the current study: sleep onset 
latency, REM latency, percentage of stage 1 NREM, 
percentage of SWS, percentage of REM sleep, number of 
arousals during the first half of the sleep period, number
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of arousals in the second half of the sleep period, number 
of stage changes, time awake after sleep onset, REM 
density, number of stage 1 NREM episodes, and percentage 
of epochs containing electrodermal storming. Based on 
available research findings, the following hypotheses were 
offered regarding variables related to depth of sleep, 
sleep continuity, electrodermal activity, and sleep onset:
1. High anxiety subjects were expected to show 
greater disruption of sleep continuity as 
reflected by higher frequency of micro-arousals, 
higher frequency of stage 1 NREM episodes, more 
time awake after sleep onset, and a greater number 
of stage changes relative to low anxiety subjects.
2. High anxiety subjects were expected to differ from 
low anxiety subjects in distribution of arousals 
across the sleep period, with high anxiety 
subjects showing a greater frequency of arousals 
during the first half of the sleep period.
3. High anxiety subjects were expected to spend a 
greater amount of total sleep time in light, 
transitional sleep (stage 1 NREM) and less time in 
deep restorative sleep (SWS) relative to low 
anxiety subjects.
4. High anxiety subjects were expected to show 
longer latency to sleep onset relative to low 
anxiety subjects.
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5. High anxiety subjects were expected to show higher 
levels of electrodermal "storming" relative to low 
anxiety subjects.
Research findings regarding the relationship between REM 
sleep variables and anxiety is inconsistent, although 
these variables have been found to be relevant to 
depression. They were included in the present 
investigation in an attempt to clarify their relationship 
to "pure" anxiety states. Although somewhat inconsistent, 
available research suggests the following patterns:
6. High anxiety subjects were expected to show 
longer REM latency, lower REM density, and lower 
REM percentage relative to low anxiety subjects.
METHOD
Subject Selection
Subjects were recruited from among the undergraduate 
population at Louisiana State University, A total of 435 
subjects underwent preliminary screening which consisted 
of the trait portion of the State-Trait Anxiety Inventory 
(STAI-trait) the Penn State Worry Questionnaire (PSWQ) and 
the Beck Depression Inventory (BDI) . The STAI-trait and 
the PSWQ, which are designed to measure the related 
constructs of trait anxiety and worry, showed a high 
positive correlation among the screening sample (r = .683, 
p < .001), which was similar to the correlation noted 
between these measures (r = .64) by Meyer and colleagues 
(1990) in their sample of 386 undergraduates. Although 
significantly correlated, the STAI-Trait and PSWQ shared 
only 47% of the variance, which is consistent with 
assertions by Meyer and colleagues that the PSWQ measures 
the independent construct of worry.
These selection measures also showed low positive 
correlations with the BDI in the screening sample: The BDI 
correlated .41 and .31 with the STAI-trait and PSWQ, 
respectively. These low, positive correlations likely 
reflect the dysphoria (or negative affect) component 
shared between generalized anxiety and depression (Clark & 
Watson, 1991/ Watson Clark & Carey, 1988). The 
characteristics of the initial screening sample, from
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which final subjects were selected, are presented in 
Table 1. STAI-trait scores are expressed in T-scores 
while PSWQ and BDI scores are expressed as raw scores.
From this sample, 36 individuals were identified as 
appropriate for screening interviews. High anxiety 
subjects were chosen from among individuals scoring within 
the upper 20th percentile on both the STAI-trait and the 
PSWQ. Low anxiety subjects were chosen from among 
individuals scoring within the lower 50th percentile on 
these measures. BDI scores were used as a matching 
variable to assure that groups did not differ on this 
measure of depression. Subjects were matched within 2 BDI 
points across groups, and individuals scoring above 15 
were excluded from further participation.
During the course of screening, five subjects met 
previously defined exclusion criteria and were eliminated 
from further participation. Subjects scoring within the 
appropriate ranges on the STAI-trait, PSWQ, and BDI, and 
who did not meet exclusion criteria, were scheduled to 
complete one night of polysomnography at the Baton Rouge 
General Medical Center. Thirty-one subjects underwent 
polysomnography. Subject groups were equated for age 
(+/- 3 years), race, and sex to avoid possible confounds. 
One subject was excluded prior to data analysis due to 
inability to recruit an age-matched subject in the other 
group. The final sample consisted of 15 subjects per
52
Table 1. Characteristics of Screening Sample (n = 435).
Measure Mean Standard Deviation
STAI-trait 52.2 11.0
PSWQ 46.7 14.9
BDI 7.5 6.2
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group; each group contained seven males, eight females, 
thirteen Caucasian and two African-American students. 
Additional sample characteristics are described in 
Table 2.
Subjects were instructed not to nap during normal 
waking hours and to rise by 8:00 am on the day of 
polysomnography. They were also instructed to abstain 
from alcoholic beverages 24 hours prior to sleep 
recordings, and not to consume caffeine after 6pm on the 
scheduled date of polysomnography. All subjects reported 
that they had been compliant with these instructions.
Hospital Procedures
Prior to scheduling of polysomnography the procedure 
was fully explained to subjects (Appendix G) . Upon 
arrival at the sleep laboratory subjects were asked to 
read and sign an informed consent for polysomnography 
(Appendix H). A standard polysomnographic hookup, which 
is fully described in Appendix I, was performed according 
the montage presented in Appendix J. Subjects slept in a 
private room in the sleep laboratory of the Baton Rouge 
General Medical Center. A research assistant was present 
to monitor them from an adjacent control room throughout 
the night. All recordings were made on a Grass 
Electroencephalograph Model 8-16 D. All subjects arrived
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Table 2. Characteristics of Final Subject Sarrple 
(n = 30) .
Measure Mean Standard Deviation
High Anxiety Subjects:
Age 24.1 (9.1)
STAI-trait 71.4 (3.8)
PSWQ 61.3 (15.7)
BDI 7.9 (2.6)
s H- (D Subjects:
Age 24.8 (9.2)
STAI-trait 43.4 (5.0)
PSWQ 30.6 (8.8)
BDI 7.1 (2.6)
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at the laboratory prior to 21:00, and hookup procedures 
were completed by 22:30.
Subjects were awakened by 06:30, the electrodes were 
removed, and they were instructed to dress for the day. 
Subjects then conpleted a sleep diary (Appendix K) in 
order to determine a subjective rating of his/her sleep 
quality during the recording period, and were given extra 
credit vouchers. If a subject had any remaining questions 
regarding the procedure they were answered at this time.
Scoring
Analysis and scoring of the polysomnographic records 
followed Rechtsaffen and Kales' (1968) standardized method 
for human subjects. Of the 30 research records, 10 were 
scored independently by 2 individuals experienced in the 
scoring of polysomnography records. These scorers were 
found to have adequate inter-rater reliability; the 
average percent agreement between independent scorers was 
92.7% (standard deviation = 2.4%, range of 88.2% to 95.7% 
agreement). Scoring of micro-arousals followed the recent 
standardized guidelines described by Bonnet et al. (1992), 
which are fully described in Appendix L.
RESULTS
Variables of interest were defined in the following 
manner: Sleep onset was defined by the number of minutes
between lights-out and initial presence of stage 2 NREM 
sleep. Micro-arousals were defined according to ASDA 
criteria as presented in Appendix L, and summed separately 
for the first and second halves of the sleep period. REM 
latency was determined by the number of minutes between 
sleep onset and initial presence of REM sleep. REM 
density was determined by dividing the number of observed 
rapid eye movements by the total minutes spent in REM 
sleep. Time awake after sleep onset was defined the 
number of minutes of wake time following sleep onset. 
Number of stage 1 NREM epochs was determined by counting
the number of independent stage 1 NREM episodes and
dividing by the total hours of sleep. Number of stage 
changes was determined by counting the total number of 
stage changes and dividing by the total hours of sleep. 
Percentage of electrodermal storming (EDS) epochs was 
determined by dividing the total number of epochs which 
contained storming activity by the total number of sleep 
epochs. Percentages of stage 1 NREM, SWS, and REM sleep 
were determined by dividing the total amount of time in 
each of these stages by the subject's total sleep time. 
Grand means and standard deviations on these 12 variables
of interest are provided in Table 3.
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Table 3. Grand means and standard deviations for the total 
subject sattple (n = 30) on the 12 dependent variables.
Variable Grand Mean Standard
Deviation
Sleep Onset Latency 35.03 minutes (26.26)
Percentage SWS 17.75% (7.54)
Number of Stage 1 NREM Periods 4.59/hour sleep (1.53)
Arousals (first half) 30.87 total (16.32)
REM Density 2.93/minute REM (1.23)
Percentage Stage 1 NREM 9.29% (5.10)
Percentage REM Sleep 17.79% (6.04)
Time Awake After Sleep Onset 30.23 minutes (25.02)
Number of Stage Changes 18.15/hour sleep (5.42)
Percentage Storming 36.57% sleep epochs (20.03)
REM Latency 111.95 minutes (53.14)
Arousals (second half) 27.73 total (11.29)
Among the 12 dependent variables, significant 
correlations were present between the number of arousals 
during the first half of the sleep period and five other 
variables: percentage of SWS (r = -.50), percentage of 
stage 1 NREM sleep (r = .73), number of stage changes 
(r = .57), number of arousals during the second half of 
the sleep period (r = .56), and number of stage NREM 1 
episodes (r = .64) . Ihe number of stage 1 NREM episodes 
was correlated significantly with three additional 
variables: percentage of SWS (r = -.47), time awake after 
sleep onset (r = .52), and number of stage changes (r = 
.60). A significant negative correlation (r = .-53) was 
also present between percentage of REM sleep and REM 
latency, in which subjects with longer REM latency showed 
a lower percentage of REM sleep. A conplete listing of 
correlations among dependent variables is provided in 
Table 4.
The data set was screened for possible outliers 
within groups. Univariate and Multivariate screenings 
were performed through separate within group comparisons 
for high and low anxiety groups. Initial data screening 
revealed the presence of one variable, number of stage 1 
NREM episodes, which contained two values representing 
univariate outliers. These data points fell more than 
three standard deviations above the high anxiety group 
mean for two subjects in the high-anxiety group. To
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Table 4. Correlations between dependent variables for 
entire subject sample (n = 30; * = p < .01,
** = p < .001).
NREM1% sws% REM% Onset REML AR1 AR2 TimeW #Chgs Storm #NREM1 REMD
NR£M1% 1.0 -.43 -.28 .03 .17 .73** .33 .36 .22 -.26 .46 -.09
SWS% 1.0 ■-.16 -.35 .05 -..50* -.06 -.40 -.16 .13 .47* .09
REM% 1.0 -.22 -.53*-..02 .08 -.32 -.06 -.04 .26 .19
Onset 1.0 -.04 .14 -.21 .36 .15 .08 .45 .29
REML 1.0 -.03 -.09 .34 .26 .13 .15 -.14
AR 1 1.0 .56* .23 .57 -.08 .64** -.03
AR 2 1.0 -.04 .34 .11 .42 .30
TimeW 1.0 .44 -.07 .52* -.07
#Chgs 1.0 -.01 .60** -.14
Storm 1.0 -.00 .24
#NREM1 1.0 - .10
REMD 1.0
KEY
NREM1% = percentage stage 1 NREM
REM% = percentage REM
TimeW = time awake after sleep onset
Storm = percentage of storming epochs
#Chgs = number of stage changes per hour sleep
#NREM1 = number of stage 1 NREM episodes
AR1 = number of arousals in first half of sleep period
AR2 = number of arousals in second half of sleep period
SWS% = percentage SWS 
Onset = sleep onset latency 
REML = REM Latency 
REMD = REM density.
eliminate the potential irrpact of extreme values during 
data analysis, these values were removed and group means 
were substituted for missing values. No other univariate 
outliers were identified, and no missing data was present 
within the data set. No within group multivariate 
outliers were identified as determined by examination of 
Mahalanobi's distance (p < .001); and evaluation of 
assumptions of normality, linearity, homogeneity of 
variance-covariance matrices, and multicollinearity 
revealed no threat of Type 1 error inflation during 
multivariate analysis.
A between-groups multivariate analysis of variance 
(MANOVA) was used for initial analysis, and the 12 
dependent variables were entered into the model 
simultaneously. With the use of Wilks' criterion, the 
high and low anxiety groups were found to differ 
significantly on the combined dependent variables, 
F(12,17) = 5.34, pc.OOl. Means and standard deviations 
for these variables are provided in Table 5.
Significant differences (Univariate F-tests) between 
subject group means suggested that high anxiety subjects 
took longer to fall asleep (longer sleep onset latency) 
and had lighter sleep (lower SWS percentage and greater 
percentage Stage 1 NREM sleep) which was more prone to 
arousal, especially during the first half of the sleep 
period (more arousals during the first half of the sleep
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period and higher number of stage 1 NREM episodes). In 
addition, high anxiety subjects showed a significantly 
lower REM density, as well as non-significant trends 
towards less REM sleep and more time awake after sleep 
onset. Univariate F-tests for dependent variables are 
provided in Table 6.
A direct discriminant function analysis (DFA) was 
then utilized to determine to what extent group membership 
(high versus low anxiety group) could be determined using 
objective polysomnography variables as predictors. A 
significant discriminant function was identified (pi <
.001) which accounted for 79.01% of the variance between 
groups on the 12 dependant polysomnography variables.
When the rule of thumb (r > .30) for interpretation 
suggested by Tabachnick and Fidell (1989) was applied, 
pooled within groups correlations between discriminating 
variables and canonical discriminant function (Table 7) 
indicated that high anxiety subjects could be reliability 
identified to show the following sleep pattern: They took
longer to fall asleep, had less SWS, and more frequent 
stage 1 NREM episodes.
Results of DFA classification procedure for the total 
sample of 30 subjects indicated that 29 (96.67%) were 
classified correctly. All high anxiety subjects and 14 of 
15 low anxiety subjects were correctly classified, while 
one low anxiety subject was classified with the high
anxiety group. The generalizability of this 
classification procedure is limited due to the fact that 
the relatively small sample size did not allow for a 
cross-validation to be performed, possibly leading to an 
artificially inflated classification rate. However, the 
primary purpose of the classification procedure in the 
current investigation was not classification, but rather 
to determine the consistency of sleep pattern across 
subjects. Results of the classification procedure did 
show that the discriminant function reliably distinguished 
among individuals across the entire subject sample. Thus, 
a frequent methodological criticism of psychiatric sleep 
research, that a few subjects account for the majority of 
the variance between groups (Anch, Browman, Mi tier, & 
Walsh, 1988) , does not apply to the current 
classification.
Arousal patterns were further investigated through a 
repeated measures analysis of variance to determine if the 
two groups differed in their pattern of arousals across 
the sleep period (i.e. first half verses second half of 
the sleep period). Results indicated that groups did not 
differ significantly in overall number of arousals 
[F(1 ,28) = 2.09, p = .16], but a significant interaction 
[F(l,28) = 9.76, pc.Ol] was present between group and 
distribution of arousals across the first versus second 
halves of the sleep period.
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Table 5. Means and standard deviations for high and low 
anxiety subjects on polysomnography dependent variables 
(* = p , .05; ** = p < .01).
Variable High Anxiety Low Anxiety
Group Group
** Sleep Onset Latency 51.03 minutes 
(13.51)
19.03 minutes 
(12.13)
** Percentage SWS 13.51%
(7.12)
21.98%
(5.34)
** Number of Stage 1 NREM Periods 5.41/hour sleep
(1.32)
3.78/hour sleep 
(1.29)
* Arousals (first half) 37.47 total 
(18.52)
24.27 total 
(10.72)
* REM Density 2.43/minute REM 
(.85)
3.42/minute REM 
(1-37)
* Percentage Stage 1 NREM 11.19%
(5.93)
7.39%
(3.30)
Percentage REM Sleep 15.86%
(5.46)
19.27%
(6.16)
Time Awake After Sleep Onset 37.63 minutes
(31.89)
22.83 minutes 
(12.73)
Number of Stage Changes 19.10/hour sleep 
(5.92)
17.21/hour sleep 
(4.89)
Percentage Storming 9.85% epochs 
(21.47)
33.30 epochs 
(18.63)
REM Latency 115.23 minutes 
(54.12)
108.67 minutes 
(53.83)
Arousals (second half) 27.47 total 
(10.95)
28.00 total 
(11.99)
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Table 6. Univariate F-tests with (1,28) degrees of 
freedom.
Variable Univariate F Univariate
Value Significance of F
Sleep Onset Latency 17.45 .000
Percentage SWS 13.57 .001
# Stage 1 NREM periods 11.64 .002
Arousals (first half) 5.70 .024
REM Density 5.65 .024
Percentage Stage 1 NREM 4.69 .039
Percentage REM Sleep 3.31 .079
Time Awake After Onset 2.79 .106
Number of Stage Changes .91 .348
Percentage Storming .80 .380
REM Latency .11 .741
Arousals (second half) .02 .900
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Table 7. Pooled within groups correlations between 
discriminating variables and canonical discriminant 
function.
Variable Correlation
*Sleep Onset Latency .40683
*Percentage SWS -.35865
*# NREM1 episodes .33214
Arousals (first half) .23260
REM Density -.23163
Percentage Stage 1 NREM .21092
Percentage REM Sleep -.17727
Time Awake After Sleep Onset .16253
Number of Stage Changes .09286
Percentage Storming .08691
REM Latency .03244
Arousals (second half) -.01239
As illustrated in Figure 2, subjects in the high 
anxiety group had a higher mean level of arousals during 
the first half of the sleep period than the low anxiety 
group, while both groups had a similar mean number of 
arousals during the second half of the sleep period.
During the first half of the sleep period, high anxiety 
subjects showed a mean of 37.47 arousals compared to the 
mean of 24.27 for low anxiety subjects. During the second 
half of the sleep period, the low anxiety subjects had a 
mean of 28.00 arousals and the high anxiety subjects had a 
mean of 27.27 arousals.
In order to clarify the interpretation of 
polysomnography dependent variables, the groups were 
conpared on additional objective sleep parameters and 
subjective sleep estimates. Evaluation of this additional 
data revealed that high anxiety and low anxiety groups did 
not differ in total amount of bed time or total sleep 
time. Thus, observed differences in dependent variables 
were not attributable to differences in opportunity for 
sleep or total amount of sleep obtained.
Estimates of subjective sleep quality were obtained 
from subjects' responses on the Daily Sleep Diary 
(Appendix K) which they filled out on the morning 
following polysomnography. Numerical values for 
subjective sleep quality were obtained by summing 
questions seven (Rate the quality of last night's sleep),
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Figure 2. Mean number of arousals across the first and 
second halves of the sleep period for high and low anxiety 
subjects.
and six (How rested do you feel this morning?) Numerical 
values for subjective estimates of difficulty falling 
asleep represent the sum of responses from questions five 
(How difficult was it for you to fall asleep last night?), 
eight (What was your level of physical tension when you 
went to bed last night?), and nine (Rate your level of 
mental activity when you went to bed last night) .
Subjects were asked to rate their sleep during the night 
of polysomnography in comparison to their sleep at home on 
a "typical" night. Subjects responded on five-point 
Likert scales with higher numbers representing poorer 
perceived sleep quality and increased difficulty falling 
asleep. The reliability of these subjective measures were 
evaluated through the use of Chronbach' s Alpha. Alpha 
coefficients were .80 for measures of sleep onset 
difficulty (questions #6 and #7; Appendix K) and .81 for 
subjective measures of sleep quality (questions #5, #8, 
and #9; Appendix K). Thus, these subjective measures 
appear to be adequately reliable. Subject groups did not 
differ in either of these subjective measures of sleep; 
both groups responded with mid-range likert scores, 
suggesting that the sleep that they obtained in the 
laboratory was neither markedly good or poor relative to a 
"typical" nights sleep. Means and standard deviations for 
these general measures are provided in Table 8.
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Table 8. Means and standard deviations for general sleep 
parameters and subjective estimates.
Variable High Anxiety 
Group
Low Anxiety 
Group
Total Time in Bed 7.35 hours 7.36 hours
(.39) (.53)
Total Sleep Time 353.23 minutes 
minutes
371.51
(50.06) (107.77)
Subjective Sleep Quality 5.66 5.60
(1.59) (1.88)
Subjective Onset Difficulty 8.20 7.47
(2.48) (2.48)
DISCUSSION
The current investigation found significant 
differences in several objective polysomnography variables 
between a group of high anxiety subjects, who were chosen 
to represent an analog GAD population, and a group of 
matched control subjects with lower anxiety levels. 
Discriminant function analysis indicated that the two 
subject groups could be differentiated by a discriminant 
function (97%) in which high anxiety subjects were 
reliability identified as taking longer to fall asleep, 
having less SWS, and showing more frequent stage 1 NREM 
episodes. MANOVA and follow-up ANOVA indicated that, in 
addition, high anxiety subjects showed a significantly 
higher frequency of arousals during the first half of the 
sleep period, lower REM density, and a higher percentage 
of stage 1 NREM sleep.
In general, these results suggest that healthy 
individuals with high levels of generalized anxiety and 
worry, and without other psychiatric co-morbidity, 
experience a pattern of sleep disruption that is very 
similar to what has been documented in clinical anxiety 
disorders, and which is quite distinct from what has been 
observed among individuals experiencing dysthymia and/or 
major depression. Hypotheses based on research data from 
studies using generalized anxiety disorder subjects 
(Arriaga & Paiva, 1990/ Papadimitriou et al, 1988;
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Reynolds et al, 1983), which predicted greater latency to 
sleep onset (Hypothesis 4), lighter sleep (Hypothesis 3), 
and disruption of sleep continuity (Hypothesis 1) , were 
supported. High anxiety subjects showed longer sleep 
latency and less deep sleep as reflected in less SWS and 
more light transitional sleep (stage 1 NREM). Disruption 
of sleep continuity in the high anxiety subjects was 
indicated both by a greater number of episodes of light 
transitional sleep throughout the night and by more 
transient arousals from sleep (micro-arousals) during the 
first half of the sleep period.
In addition, the pattern of micro-arousals across the 
sleep period in high anxiety subjects was found to differ 
from low anxiety subjects in a manner which supported 
Hypothesis 2, and was consistent with previous research 
findings in clinical samples suffering from Post-Traumatic 
Stress Disorder (Fuller, Waters, & Scott, in press; Kramer 
& Kinney, 1988) : The high anxiety subjects, like PTSD
subjects, showed a greater arousability during the first 
half of the sleep period relative to low anxiety subjects 
and normal controls. This finding suggests that the 
observed pattern of micro-arousals in individuals with 
PTSD is likely to be a function of the elevated baseline 
anxiety (and perhaps worry) prevalent in the PTSD 
population, and is not specific to individuals who have 
been previously exposed to a traumatic event.
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This shared component of elevated baseline 
anxiety/worry may also account for other (PSG) findings 
that were common to both PTSD patients and analog GAD 
subjects in the present investigation. In addition to 
increased arousability during the first half of the sleep 
period, both satrples had low sleep efficiency (longer 
sleep latency and time awake after sleep onset), lower 
amounts of deep restorative sleep (SWS), and more light 
transitional sleep (stage 1 NREM) (Astrom et al, 1989; 
Fuller et al, in press; Glaubman et al, 1990; Kramer & 
Kinney, 1988; Mellman et al, 1993; van Kammen et al,
1990).
Results of the present investigation are also 
generally consistent with recent research findings from a 
sample of panic disorder (PD) patients who were relatively 
free of co-morbidity (Stein et al., 1993). These panic 
disorder patients showed a significantly higher number of 
stage 1 NREM episodes and less SWS relative to matched 
controls, and their sleep disturbance was most pronounced 
during the first half of the sleep period. Thus, it 
appears that the pattern of disrupted sleep continuity and 
disturbed depth of sleep shown by the analog GAD subjects 
in the current investigation is consistent with findings 
among clinical research samples including GAD, PTSD, 
and PD.
The lack of sleep depth (low percentage of SWS and 
high percentage of stage 1 NREM) and disruption of sleep 
continuity observed during the current investigation were 
also generally consistent with previous research 
investigating sleep parameters among non-clinical 
populations with high trait anxiety (Rosa et al, 1983) and 
in human and animal populations exposed to chronic, 
ongoing stressors (Anch, Orr and Karacan, 1976; Landis et 
al., 1989; Lester, et al, 1967; Marczynski & Urbancic, 
1988). However, subjects in the current investigation did 
not show the significant mean increase in electrodermal 
activity predicted in Hypothesis 5 which has been 
previously noted among individuals exposed to the ongoing 
stress of medical school exams (Lester et al, 1967), nor 
did they show the low levels of electrodermal storming 
previously observed among individuals with chronic PTSD 
(Fuller et al, in press).
Thus, results of the current investigation failed to 
directly clarify the apparently complex relationship 
between chronic anxiety states, situational stressors, and 
electrodermal activity during sleep. However, hints about 
this relationship were provided when data from the current 
study were subjected to an additional analysis in which 
SWS percentage, REM percentage, and REM density were co- 
varied to remove their theorized influence on 
electrodermal storming (EDS).
In the context of normal sleep, EDS activity occurs 
primarily during SWS (Koumans et al, 1968) . Therefore, it 
was hypothesized that individual differences in the amount 
of SWS may have affected the "window of opportunity" for 
EDS activity. Previous research has also shown that EDS 
is rare in REM sleep (Koumans et al, 1968; McDonald et 
al., 1976), probably due to inhibited thermoregulation 
during REM sleep. Therefore, the impact of individual 
differences in the prominence of REM sleep (as measured by 
the percentage of REM and REM density) were also seen as 
possible confounding variables effecting the "window of 
opportunity" for electrodermal activity.
In order to control for the hypothesized effects of 
these variables on EDS activity, the percentage of SWS,
REM sleep percentage, and REM density were entered as co- 
variates in a hierarchial MANOVA framework. When these 
variables were co-varied, stepwise analyses indicated that 
the percentage of storming assumed a significant value 
(Roy-Bargmann Stepdown F (1,25) = 7.61, p < .01), with 
high anxiety subjects showing a significantly greater 
percentage of storming epochs. These findings indicate 
that the relation between electrodermal storming and 
anxiety is complex, as it is affected by the degree of 
both SWS and REM sleep.
The present findings, that high anxiety subjects had 
more electrodermal storming and less SWS than low anxiety
subjects, is consistent with previous research findings 
which indicate that, among healthy young adults, anxiety 
states both decrease the amount of SWS observed during 
polysomnography and increase storming activity (Lester et 
al., 1967). However, the relationship between anxiety, 
EDS, and REM sleep variables among subjects in the current 
investigation is less clear. Although the mean percentage
of REM sleep the high anxiety subjects was smaller than
for the low anxiety groups, the groups were not 
statistically different on this measure. High anxiety 
subjects did show a significantly lower REM density, which 
is suggestive of less sleep satiation (Aserinsky, 1969; 
1971; 1973). These findings suggest that, for high
anxiety subjects as a group, REM sleep was somewhat less
prominent in their sleep architecture. Given its 
importance as a co-variate, REM percentage, though not 
significantly lower for high anxiety subjects, still 
exerted influences on EDS. Thus, the results of the 
current investigation provide possible clues to the 
relation between anxiety and nocturnal electrodermal 
storming activity, an apparently complex interaction 
between EDS activity, SWS percentage, REM percentage, and 
REM density. However, the exact relationship between 
trait anxiety and EDS activity requires further 
investigation.
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In attempting to clarify the inpact of trait anxiety 
upon sleep architecture, the pattern of correlations 
between dependent variables in the current investigation 
is of theoretical interest. The number of arousals during 
the first half of the sleep period was positively 
correlated with several variables, including the number of 
stage 1 NREM periods, percentage of stage 1 NREM sleep, 
and number of stage changes. It appeared that increased 
early arousals were associated with more frequent overall 
stage changes, and specifically with shifts into light, 
transitional sleep; and that such shifts were associated 
with overall increases in percentage of the sleep period 
spent in light sleep. In contrast, both the number of 
arousals during the first half of the sleep period and the 
number of shifts into light, transitional sleep were 
negatively correlated with the percentage of the sleep 
period spent in deep, restorative sleep (SWS).
These patterns strongly suggest a relation between 
repeated arousals during the early portions of the sleep 
period and less sleep depth (more light sleep and less 
SWS) . However, due to the correlational nature of 
findings, it can not be determined to what extent either 
increased early arousability or decreased SWS is the 
causal element in this relation, or whether a third 
underlying mechanism is accounting for the observed 
relations. However, as these variables also were found to
differ between high and low anxiety/worry subjects who 
were otherwise equivalent, the anxiety/worry variable 
appears to have explanatory power. Anxiety level may 
account for observed polysomnography (PSG) findings 
indirectly through the reduction of sleep depth (less SWS, 
more stage 1 NREM), permitting arousals by external 
stimuli which would not arouse individuals in deeper 
stages of sleep. Conversely, anxiety level may have acted 
to increase arousability directly, especially during the 
first half of the sleep period, via the direct inhibition 
SWS and a congruent increase in stage 1 NREM.
Previous research has indicated that increased 
arousals may represent the causal factor in observed PSG 
findings; micro-arousals produced by external stimuli 
during the nocturnal sleep period have been demonstrated 
to result in suppression of SWS, as well as degraded mood 
and increased sleepiness upon awakening (Bonnet, 1985; 
1986a; 1986b; 1987). However, further research is needed 
to clarify possible causal links between reduced SWS and 
increased arousability during the first half of the sleep 
period, and to determine to what extent relations between 
these variables may be specific to anxious samples. In 
answering these questions it would be inportant to 
investigate whether similar relations are present in 
groups of individuals defined by other variables 
associated with SWS decrements; such as age, depression,
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or schizophrenia (Benca et al., 1992; Williams et al., 
1974), or whether they are specific to anxious 
individuals.
The current investigation failed to find significant 
differences between high and low anxiety groups in REM 
latency or percentage of REM sleep (Hypothesis 6), 
variables which have been highly inconsistent in anxiety 
disorder samples, but which have been observed to differ 
consistently between depressed patients and controls. REM 
sleep abnormalities which typically have been observed in 
depressed samples include shortened latency to the first 
REM period and increased REM percentage, especially during 
early portions of the sleep period (Benca et al., 1992; 
Reynolds & Kupfer, 1987). Failure of the current 
investigation to find reliable evidence of differences in 
these variables between "pure" samples of healthy young 
adults with high versus low trait anxiety suggest that 
previous inconsistent research findings may have been a 
reflection of co-morbidity confounds among psychiatric 
subjects; specifically, depression in anxiety disorder 
patients acting to decrease REM latency and increase REM 
percentage and density.
However, Hypothesis 6 was supported in that a 
significant difference between groups in REM density was 
found. Research findings in depressed samples have also 
consistently found increased REM density relative to
matched controls (Benca, Obermeyer, Thisted, & Gillin, 
1992; Mendlewicz & Kerkhofs, 1991; Reynolds & Kupfer,
1987). REM density appears to represent the most robust 
biological marker, across age ranges, differentiating the 
sleep of depressed individuals relative to anxious and 
normal control subjects (Lauer Riemann, Wiegand, & Berber,
1991). Differences in REM density were observed in the 
current investigation, with high anxiety subjects showing 
a lower REM density. This result is consistent with 
previous research findings in panic disorder patients 
(Uhde, et al., 1984), and is opposite of the pattern which 
characterizes depressed individuals.
REM density has been hypothesized to be an indication 
of sleep satiation, with greater REM density indicating 
higher levels of satiation. In studies of healthy young 
adults permitted to sleep to their fullest capacity, REM 
density has been found to increase throughout the sleep 
period (Aserinsky, 1968; 1971; 1973), reaching its maximal 
capacity at 7.5 to 10 hours. Furthermore, when subjects 
were studied continuously across a 54 hour period, prior 
sleep was found to be positively correlated with REM 
density, whereas the length of previous waking period was 
negatively correlated (Aserinsky, 1973) . When viewed in 
this context, the significantly lower REM density found in 
the high anxiety group may be considered an indication 
that these subjects have not reached a level of sleep
satiety equal to that of the less anxious subject group. 
This explanation is consistent with research indicating 
that more anxious individuals tend both to report 
preferring to sleep for longer periods of time (McCann & 
Stewin, 1987) and to show evidence of increased daytime 
sleepiness (Roehrs, Timms, Zwghuizen-Doorenbos, Buzenski,
& Roth, 1990) relative to less anxious control subjects. 
Thus, the observed differences in REM density between 
groups appears to reflect decreased sleep satiation in 
high anxiety subjects, which is likely a function of the 
decreased sleep depth and continuity also documented in 
polysomnography findings.
The present investigation failed to find significant 
differences between high and low anxiety groups in overall 
number of stage changes or in total time awake after sleep 
onset. These measures appear to have been less sensitive 
than other measures included in the analysis. The number 
of stage changes, which reflected both shifts into lighter 
and deeper stages of sleep, appeared to be less sensitive 
to differences in anxiety levels than a measure that 
represented only shifts into light, transitional sleep 
(number of stage 1 NREM episodes). In a similar manner, 
the number of waking epochs appeared to be less sensitive 
to differences in anxiety level than the prevalence of 
micro-arousals early in the sleep period and the number of 
stage 1 NREM episodes. This suggests that it was the
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disruption of sleep micro-structure, rather than the time 
spent consciously awake, that was influenced by anxiety.
The finding that the two groups did not differ in 
subjective self-report measures of sleep quality was 
unexpected given the significant differences found between 
the groups in objective PSG measures of sleep depth and 
continuity. This contradiction between objective and 
subjective measures appears to have resulted from the 
method used to assess subjective sleep quality, in which 
subjects were asked to compare how they slept in the 
laboratory to a "typical" night of sleep for them.
Subjects who felt that they "typically" slept badly may 
have given subjective estimates of a bad night in the lab 
which, although non restorative, was no worse than usual. 
These scores would not differ from scores of subjects who 
typically slept well and also slept well in the lab.
The fact that subjects spent only one night in the 
sleep laboratory creates a possible confound when 
comparing the results of the current study with previous 
research findings. The first night in the sleep 
laboratory has been shown to be associated with increased 
sleep latency, decreased REM, and decreased stage 4 sleep 
in normal individuals (Williams, Karacan, & Hursch, 1974). 
This effect is lessened with subsequent nights spent in 
the laboratory setting, and has resulted in the common 
research practice of allowing an adaptation night in the
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sleep laboratory prior to data collection. This proved 
unfeasible in the present investigation due to limited 
resources and need to maximize sample size.
Control subjects showed indications of a possible 
mild first night effect in that they showed slightly less 
REM sleep and slightly more stage 1 NREM sleep than 
predicted by normative values for their age range 
(Williams et al, 1974). However, polysomnography results 
indicated that control subjects' percentage of SWS, sleep 
onset latency, and REM latency fell within expected ranges 
despite the absence of an adaption night. Thus, the 
current data do not suggest the presence of a noteworthy 
first night effect among control subjects. Due to the 
lack of a relevant comparison group, it is difficult to 
determine to what extent a first night effect may have 
been present among high anxiety subjects. However, 
because the sleep of high and low anxiety subjects was 
examined under identical experimental conditions the 
absence of an adaption night is not problematic in 
interpreting the current results. Furthermore, previous 
research findings regarding possible differences in 
response to the first night spent in the sleep laboratory 
for anxious subjects do not suggest that these individuals 
show a more disrupted sleep pattern under novel conditions 
than do normal control subjects. Rather, available 
research has suggested that clinical anxiety disorder
83
samples (including PTSD and GAD) as well as non-clinical 
samples of highly anxious subjects, show few changes from 
the first to the second nights spent in a sleep laboratory 
(Reynolds et al., 1983; Rosa et al., 1983; van Kammen et 
al., 1990), and may actually show less habituation to the 
lab environment than control subjects (van Kammen et al., 
1990). These latter findings actually suggests a possible 
second night confound when comparing anxious and normal 
control subjects. Thus, the possible presence of a first 
night effect does not appear to represent a confound in 
the interpretation of observed differences in 
polysomnography variables between the high and low anxiety 
groups in this study.
Summary and Implications
Results of the current investigation suggest that a 
characteristic pattern of sleep disturbance is present in 
highly anxious and worried individuals without co­
morbidity and other confounds prevalent in the psychiatric 
literature. Objective polysomnographic findings indicate 
that the sleep pattern of these individuals is consistent 
with patterns documented in various anxiety disorder 
samples, and is clearly distinct from that shown in 
individuals with depressive disorders. High anxiety 
subjects were reliably identified as taking longer to fall 
asleep, having less SWS, and showing more frequent stage 1
NREM episodes than low anxiety subjects. Hie high anxiety 
subject group also showed a significantly higher frequency 
of arousals during the first half of the sleep period, 
lower REM density, and a higher percentage of stage 1 NREM 
sleep than the low anxiety subject group. In addition 
being statistically different, this observed sleep 
disruption in highly anxious subjects appears to represent 
a clinically significant phenomenon. In contrast to low 
anxiety control subjects, who fell within normal ranges, 
high anxiety subjects showed clinically significant sleep 
onset insomnia and decreased sleep depth. Although no 
significant differences in mean EDS levels were present 
during initial analyses, when SWS and REM variables were 
entered as co-variates, results suggested that high 
anxiety subjects showed relatively higher levels of EDS 
activity than low anxiety subjects.
Disruption of sleep continuity and diminished SWS has 
been documented in both anxious and depressed samples 
(Benca et al., 1992). However, the relation between 
anxiety level and REM sleep variables observed during the 
current investigation is distinct from patterns documented 
in depressed satrples. Current results revealed that 
typical REM findings in depressed samples, which include 
increased REM density, decreased REM latency and increased 
REM percentage, are absent among individuals with "pure" 
trait anxiety. In fact, anxious and worried subjects
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showed less REM density than low anxiety control subjects, 
findings opposite that of depressed subjects.
Decreased REM density in a group of subjects with 
"pure" trait anxiety suggests that, although disruption of 
sleep depth and continuity are not unique to anxiety 
disorder populations, decreased SWS in anxious individuals 
may be associated with a specific unique decrement in 
sleep satiation. In this context, it is particularly 
noteworthy that the disruption of sleep in anxious 
individuals in the current investigation appeared to occur 
primarily during the initial portion of the sleep period, 
a time which is characterized by a prominence of deep 
sleep and low arousability in normal subjects. This 
portion of the sleep period has also been shown to be 
significantly disrupted in clinical anxiety disorders, and 
has been specifically associated with episodes of 
nocturnal panic among PD subjects (Mellman & Uhde, 1989) 
and traumatic nightmares among individuals diagnosed with 
PTSD (Kramer & Kinney, 1988; van der Kolk et al., 1984).
This pattern suggests that the sleep of anxious 
individuals may be particularly vulnerable to disruption 
during early portions of the sleep period. Thus, future 
researchers should give specific attention to the initial 
half of the sleep period. In addition, further 
investigation of this initial disruption may provide clues 
regarding the relations between, and possible underlying
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mechanisms accounting for, objective polysomnography 
findings and other symptoms, such as the hyper-vigilance 
and psychophysiological insomnia frequently observed in 
anxiety disorder populations.
In conclusion, results of the current investigation 
indicate that anxiety and worry affect are associated with 
disrupted sleep, independent of whether or not a diagnosed 
anxiety disorder is present. Current results indicate 
that these factors are associated with a pattern very 
similar to the sleep disruption observed in anxiety 
disorders, independent of the presence of panic, previous 
exposure to trauma, or a disease process per se. The 
relatively strong findings in the present study, in 
comparison to the often inconsistent findings in clinical 
anxiety disorder samples, suggest the need to concentrate 
on controlling for co-morbidity and other confounds 
frequently present in psychiatric subject samples. In 
addition to atterrpting to recruit relatively "clean" 
clinical subjects, future investigations of sleep profiles 
in psychiatric samples should avoid premature inclusion of 
"mixed" diagnostic groups until such time as the specific 
impact of trait anxiety upon sleep is understood. Prior 
to such understanding, future research which attempts to 
clarify the possible causal links between reduced sleep 
depth, disrupted sleep continuity, and anxiety/worry is 
needed. Replication of the reduced REM density finding
among high anxiety subjects, as well as the apparently 
conplex relationship between anxiety level, EDS, SWS, REM 
variables are also indicated in order to evaluate the 
robustness of these findings and to establish to what 
extent they may be specific to anxious and worried 
individuals.
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APPENDIX B 
PENN STATE WORRY QUESTIONNAIRE
Please mark the following items with the number (1-5) 
which best indicates how well the statement describes you.
1 2 3 4 5
Not typical of Very typical
me at all of me
1.   If I do not have enough time to do everything, I
do not worry about it.
2. _____ My worries overwhelm me.
3. _____ I do not tend to worry about things.
4. _____ Many situations make me worry.
5. _____ I know I should not worry about things, but I
just cannot help it.
6. _____ When I am under pressure I worry a lot.
7. _____ I am always worrying about something.
8._______ I find it easy to dismiss worrisome thoughts.
9. _____ As soon as I finish one task, I start to worry
about everything else I have to do.
10. _____ I never worry about anything.
11. _____ When there is nothing more I can do about a
concern, I do not worry about it anymore.
12. _____ I have been a worrier all of my life.
13. _____ I notice that I have been worrying about things.
14. _____ Once I start worrying, I cannot stop.
15. _____ I worry all of the time.
16. _____ I worry about projects until they are done.
100
APPENDIX D 
GENERAL INFORMED CONSENT
I hereby agree to participate in a research project 
designed to study the sleep patterns of undergraduates. I 
understand that I will be asked to conplete questionnaires 
and answer interview questions regarding my sleep 
practices and mood, as well as my use of medications and 
other substances which are known to influence sleep. I 
understand that my participation is voluntary and that I 
am able to discontinue at any time without penalty. I 
further understand that my responses are confidential and 
that my name will in no way be associated with the data 
from the study. I acknowledge that I have been given an 
opportunity to ask questions regarding study and 
understand that I may ask questions following the 
completion of the study.
Your Name Date
Researcher
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APPENDIX E 
SCREENING INTERVIEW
Subject Number:
1. Previous Psychiatric History:
Have you ever had treatment of been hospitalized for 
anxiety, depression, alcohol abuse or other emotional of 
psychological problems? Y N
If Yes to 1- When did these problems occur?
2. Panic Disorder:
Have you had times when you felt a sudden rush of intense 
fear or discomfort in which you felt physical symptoms 
such as shortness of breath, rapid heartbeat, trembling, 
shaking, choking sensations, nausea, dizziness, or chest 
pain; and/or were concerned that you would loose your mind 
or die? Y N
If Yes to 2
Have these feelings come "out of the blue" or 
unexpectedly? I mean that they were not associated with a 
particular situation and did not occur only while you were 
ill or under the influence of a substance such as 
caffeine. Y N
How many times has this happened during the past month?
3. Post-Traumatic Stress Disorder:
Have you experienced any extremely stressful, life 
threatening or traumatic event such as serious physical 
injury, assault, or seeing someone badly hurt or killed in 
the past which still troubles you? Y N
If Yes to 3
Do you reexperience this event through "flashback" 
episodes or nightmares? Y N.
Do you have intrusive thoughts about this event or 
experience extreme anxiety in situations which remind you 
of this event? Y N
4. Social/Simple Phobia
4a. Are you unusually afraid of objects or situations the 
average person is not disturbed by, such as heights, air 
travel, or certain animals? Y N
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If yes to 4a
What objects or situations cause you
anxiety?_________________________________________________
Does this situation or object always make you very 
anxious, and do you feel that your fear is excessive and 
somewhat unreasonable? Y N
Do you avoid situations which may evoke this fear? Y N
Do your fears and/or your avoidance associated with 
this object or situation interfere with your daily life?
Y N
4b. Are you uncomfortable doing certain things most 
people do; like eating in a restaurant, using a public 
restroom or speaking in a group of people because you are 
afraid of embarrassing yourself? Y N
If yes to 4b
What type of activities make you very 
uncomfortable?
Does this discomfort interfere with your social life 
or your ability to successfully perform your job or 
schoolwork? Y N
5. Obsessive-Compulsive Disorder
5a. Are you bothered by recurrent thoughts, impulses, or 
images that you can't stop from coming into your mind, and 
which you feel are intrusive and senseless? This is not 
the same as worrying about things that might happen. I 
mean things like a parent having repeated inpulses to kill 
a loved child, or a religious persons having recurrent 
blasphemous thoughts. Y N
If Yes to 5a-What kind of thoughts trouble
you?______________________________________________________
Do you try to ignore these thoughts or do something to 
keep them out of your mind? Y N
BBT- Do you often repeat some act over and over again that 
doesn't seem to make sense and that you find distressing; 
such as washing something over and over, counting things 
or checking something repeatedly? Y N
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If Yes to 5b-What are these actions? Are they related to 
certain situations?
6. Major Depression:
Did you ever have a period of time, which lasted 2 weeks 
or longer, when you felt depressed, sad, hopeless, or lost 
interest in almost all of your usual activities? Y N
If yes to 6
During this time did you notice changes in your 
appetite, sleep or energy level? (if yes) What kinds of 
changes did you notice?
How about changes in the way you felt about yourself 
and the future such as feelings of low self esteem, 
worthlessness, or hopelessness? (if yes) Tell me about 
these feelings___________________________________________
During this time did you notice any differences in 
your ability to think or make decisions? (if yes) Tell me 
about these changes
Have you been feeling this way nearly every day for 
the last two weeks? Y N
7. Dysthymia:
In the last two years have you felt down, blue, depressed 
or have lost interest in things that usually give you 
pleasure? Y N
If yes to 7
Have you felt this way more days than not for most of 
the day during the past two years? Y N
What is the longest period during the past two years 
in which you did not feel down or depressed? __________
8. Mania/Hypomania
Did you ever have a period of time, at least several days 
long, when you felt extremely good or high- a feeling very 
different from just being in a "good mood?" I am talking 
about things like feeling that you possessed special 
powers, having a decreased need for sleep, racing 
thoughts, or feeling a pressure to keep talking such that 
others were not able to keep up with you in conversation.
Y N
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If yes to 8
Tell me about this time; did you do anything that 
caused negative consequences such as unrestrained spending 
or sexual activity?
Did you spend a lot more time than usual doing things 
like studying, working, or social activities?
9. Psychosis:
Has there ever been a period of time when you had strange 
experiences such as hearing voices or seeing visions which 
other people could not see or hear? Y N
Have there ever been a time when people had trouble 
understanding you because your speech was mixed up or 
because you didn't make sense in the way that you were 
talking? Y N
Have you ever had the feeling that something odd was going 
on around you, that people were doing things to test you 
or antagonize you or hurt you so that you felt you had 
constantly be on guard? Y N
If yes to 10- When did this happen, explain
Did you have difficulty performing your usual activities, 
maintaining your social relationships, and/or taking care 
of yourself during this time?
10. Substance Abuse
How much do you usually drink?^______________ ________
Do you take recreational or illegal drugs such as 
marijuana, LSD, Cocaine? Y N
If subject reports alcohol or drug use
How often and in what situations do you typically use 
drugs/alcohol
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Has the use of drugs or alcohol ever interfered with 
your school or work performance, or interfered in your 
relationships with friends and family? Y N If yes, how 
has it interfered?
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INSTRUCTIONS
111 The Sleep Disorders Inventory is a questionnaire that is designed to obtain
information that will assist in the description and diagnosis of a patient's sleep 
disorder. It also provides information that is helpful in determining the causes and 
the correct treatment of a patient's sleep disorder.
xxx Please answer these questions to the best of your ability. It is understood that some 
of your answers will be approximations, not exact. Such estimates are acceptable.
Also, a few of the questions may require information from a person who has observed 
your sleep. If you have access to such information, feel free to use it.
1X1 If you are asked to give a YES NO answer, and you are not certain of your response,
give the answer that is closest to the truth as best you can determine. If you are 
asked to give a numerical ansvrer, such as the number of minutes it takes you to fall 
asleep, and you are not certain, give an approximate answer that is closest to the 
truth as best you can determine.
xxx Please answer ALL of the questions. If a YES NO item does not apply to you, answer
NO. If you encounter an item that calls for a numerical response and it does not
apply to you, or you cannot give an estimate, the number 0 will Indicate that it does 
not apply or that you cannot estimate.
xxx Before conpleting the SDI, please provide the following information:
NAJiE: ___________________________________________  DATE: ____________________ __
SOCIAL SECURITY NUMBER: _________________________  CLINIC NUMBER: ,______________
THE SLEEP DISORDERS INVENTORY BEGINS ON THE NEXT PAGE.
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* Please CIRCLE the appropriate response for each of the YES_NO questions. Please FILL IN
THE BLANK with the correct number for each question that is followed by a blank.
1. Do you have difficulty falling asleep at night?............................... YES__NO
*** If your answer Is NO, go to the next item. If your answer is YES, go to (a).
(a) How many NIGHTS per WEEK do you usually have difficulty?................... .......
(b) On nights when you have difficulty falling asleep, how many MINUTES does 1t 
usually take you to fall asleep?........................................... .......
(c) On nights when you have this problem, how many HOURS do you sleep?......... .......
2. How many MINUTES does it usually take you to fall asleep on your BEST nights?..._______
3. Oo you wake up during the night and have difficulty falling back to sleep..... YES__NO
*** If your answer is NO, go to the next Item. If your answer is YES, go to (a).
(a) About how many NIGHTS does this happen each WEEK?.......................... .......
(b) On the average, how many TIMES do you wake up 9ach NIGHT?.........................
(c) How many MINUTES does it take you to fall asleep after awakening?.......... .......
(d) On nights when you have this problem, how many HOURS do you sleep?......... .......
•4. Do you wake up 1n the morning before your scheduled wake time, and are unable to
return to sleep?________________________________________________________________ YES__NO
*** If your answer is NO, go to the next Item. If your answer is YES, go to (a).
(a) How many TIMES per WEEK do you have this problem?.................................
(b) On nights when you have this problem, how many HOURS do you sleep?......... .......
Do you wake up during the night frequently, but fall asleep soon afterwards?....YES NO
*** If your answer is NO, go to the next Item. If your answer is YES, go to (a).
(a) How many TIMES a NIGHT do you wake up?...........................................
fb) How many NIGHTS each WEEK do you have this problem?...............................
S. How many HOURS do you sleep on your BEST nights?......................................
T. Does your bed partner disturb your sleep at night?.............................. YES_NO
*** If your answer is NO, go to the next item. If your answer is YES, go to (a).
(a) Is this a reason for your insomnia SOME of the time?....................... YES_NO
< b) Is this the reason for your insomnia MOST of the time?......................YES_NO
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8. Is your sleep disturbed by environmental factors such as traffic, neighbors or
family members? YES NO
*** If your answer is NO, go to the next Item. If your answer 1s YES, go to (a).
(a) Is this a reason for your Insomnia SOME of the time?........................ YES_NO
(b) Is this the reason for your Insomnia MOST of the time?...................... YES_NO
9. Is your bedroom dark enough for sleep at night?..................................YES_NO
*»* If your answer 1s YES, go to the next item. If your answer 1s NO, go to (a).
(a) Is this a reason for your Insomnia SOME of the time?........................ YES_NO
(b) Is this the reason for your Insomnia MOST of the time?...................... YES_NO
10. Is your bedroom temperature comfortable enough for sleep at night?...............YES_NO
*** If your answer 1s YES, go to the next Item. If your answer is NO, go to (a).
(a) Is this a reason for your Insomnia SOME of the time?........................ YES_NO
(b) Is this the reason for your Insomnia MOST of the time?...................... YES NO
11. How many NIGHTMARES have you had in the last MONTH?............................ .......
(a) How many TIMES in the last MONTH have nightmares awakened you?............. .......
(b) How INTENSE are your nightmares (Rate 1,2,3,4, or 5; where 1-mlld,
3-frightening, 5=terr1fy1ng)?.............................................. .......
12. Do you often move vigorously during your sleep, especially while dreaming,
and sometimes even hurt your partner by accident, or fall out of bed?............YES_NO
13. Have you ever awakened from a deep sleep sweating, your heart beating fast or 
pounding, with a feeling of fear but with no memory of a dream?_________________ YES_NO
*** If ycur answer 1s NO, go to the next item. If your answer is YES, go to (a).
(.a) How many TIMES in the last MONTH has this happened?........................ .......
(b) How INTENSE was this experience (Rate 1,2,3,4, or 5; where 1-mi Id,
3-frightening, 5-terrifying)?.............................................. .......
14. How many NIGHTS per MONTH do you:
Snore loudly
Thrash about while asleep (but are not dreaming)
  Gasp or snort while asleep
  Stop breathing while asleep
  Wake up in the night and feel unable to breathe
'■S. Do you often awaken with headaches?_____________________________________________YES__NO
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16. Do you sleep enough hours but have trouble waking up, feeling unrefreshed?______ YES_NO
17. Do you sleep enough hours but fall asleep Involuntarily during the day, but
only when relatively unstimulated?______________________________________________YES__NO
18. Do you sleep enough hours but fall asleep Involuntarily during the day, even
when doing something very Important, like driving?.............................. YES_NO
19. Do you sleep enough hours but still have trouble functioning during the day?____ YES_NO
20. Do you ever wake up because your legs jerk repeatedly while you are asleep?.....YES_NO
a** Answer only if YES: How many NIGHTS per MONTH does this occur?............ .......
21. Do your legs ever feel restless or odd after you go to bed at night, and it
keeps you awake?_________________________________________________________________YES_NO
Answer Only if Y'ES: How many nIuhts per MONTH does this occur?............ .......
22. Do you walk in your sleep?______________________________________________________ YES_NO
*** If your answer is NO, go to the next item. If your answer is YES, go to (a).
(a) How many TIMES a MONTH does this happen?................................... .......
(b) About how many MINUTES pass by while you are sleepwalking?................. .......
23. Do you talk in your sleep?....................................................... YES_NO
24. Do you grind your teeth 1n your sleep?...........................................YES_NO
25. Do you suddenly sit up in bed. still asleep, then lie down agsin?............... YES_NO
26. Do you ever wet your bed while asleep?.......................................... YES_NO
27. Do you experience extreme weakness in any of your muscles or even col lapse,when
vou are excited. ngrynijs> emotional, or laughing?............................... YES_NO
28. Do you often see things that are not there, as you are falling asleep or
waking up?....................................................................... YES_NO
?9. no you often feel paralyzed while falling aslsep or waking up?.................. yes_No
30. Do you ever work the night shift, for example 11 p.m.-7 a.m.?................... YES_NO
*** Answer only if YES: How many NIGHTS per MONTH?............................ .......
31. Does lack of sleep often cause you to fall asleep at inappropriate times or in
the wrong place during the day?................................................. YES_NO
32. Does lack of sleep often cause you to have trouble functioning during the day?..YES__NO
33. Do you ever bring work home and do 1t after 8:00 p.m.?......................... YES_NO
*** Answer only 1f YES; How many NIGHTS per WEEK?............................. .......
34. On weekends or your days off, do you sleep more than an hour later than your
usual wake up time?.............................................................. YES_NO
114
SLEEP DISORDERS INVENTORY
35. How many TIMES per NIGHT do you wake up to use the bathroom?..........................
36. How many NIGHTS per WEEK do you wake up with Indigestion or heartburn?...............
37. Do you eat your last meal or a large snack within 3 hours of bedtime?............YES_NO
38. Are you on a weight loss program?............................................... YES_NO
39. Do you engage in some kind of regular physical exercise?.................. YES_NO
40. Do you exercise at night, within four hours of bedtime?................... YES_NO
41. How many GLASSES (bottles/cans) of alcoholic drink do you have each DAY?..............
42. How many NIGHTS each MONTH do you use alcohol to aid sleep?...........................
43. How many CUPS or GLASSES of caffeinated beverages do you drink 1n a DAY?..............
44. How many DAYS a WEEK do you drink caffeinated beverages after 6 p.m.?.................
46. How many CIGARETTES a DAY do you smoke?........................................ .......
46. Do you take any medications that contain caffeine or stimulants, such as allergy 
medications, nasal decongestants, or pain killers?..............................YES_NO
**» Answer only 1f YES: How many MINUTES before trying to sleep do you take it?_______
47. Is your sleep problem sometimes worse than other times?................... YES_NO
*** If your answer is NO, go to the next item. If your answer 1s YES, go to (a).
(a) Is it worse when you are under stress?...................................... YES_NO
(b) Is it better when you sleep away from home?................................ YES_NO
48. Was the onset of your sleep problem related to any specific event?............... YES_NO
*** If your answer is NO, go to the next item. If your answer 1s YES, go to (a).
(a) Were you under unusual stress at the onset of your sleep problem?........... YES_NO
(b) Were you very ill or 1n pain at the onset of your sleep problem?............ YES_NO
49. Is your sleep problem caused or made worse by physical discomfort or pain:
 Never: ____ Rarely;_____ Sometimes; Often; ____  Most or all of the time.
50. Wnen you try to sleep, is it hard for you to turn off your mind?................ YES_NO
51. When you have sleep problems, do you:
(a) Go to bed earlier on some nights to make up lost sleep?.....................YES_NO
(b) Wake up later on some mornings to make up lost sleep?...................YES_NO
(c) Get up out of bed and watch television, read, catch up on work, cr eat? YES___NO
SLEEP DISORDERS INVENTORY
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(d) Take naps during normal waking hours?..................................... YES NO
*** If your answer is NO, go to the next item. If your answer Is YES, go to (1).
(1) How many TIMES per WEEK do you take naps?................................ _ _ _ _ _
(2) How many MINUTES are your naps, on average?.............................. .......
(3) Oo you awaken from your naps refreshed?.................................. YES NO
52. Have you been under more stress than usual recently?.......................... YES NO
£3. A.-s you ths kind of person who tends to worry a lot?.......................... YES_NO
54. Does your sleep problem affect your mood during the day?...................... YES NO
55. Have you ever been treated or hospitalized for mental, emotional, drug, or
alcohol problems?.............................................................. YES NO
56. Have you ever had any convulsions or significant head Injury?.................. YES NO
57. How long have you had your sleep problem?  Years  Months  Weeks
58. Have you previously received non-drug treatment for sleep problems?............ YES__NO
59. Have you recently taken any prescription or over-the-counter medication for
sleep problems?........................................................ . >YES NO
*** If your answer 1s NO, go to the next Item. If your answer is YES, go to (a).
(a) How many NIGHTS a WEEK do you usually take this medication?.....................
(b) How many MONTHS have you been taking sleep medication?..........................
60. Please list which medications you are now taking and the condition for which each is 
being taken. Include over-the-counter medications.
MEDICATION
1
CONDITION
5
MEDICATION CONDITION
•> 6
3 7
4 8
Please list any medications you have recently 
which each was being taken. Include over-the-
stopped taking and the 
■counter medications.
condition for
MEDICATION CONDITION MEDICATION CONDITION
1 4
2 5
3 6
*** THANK YOU FOR COMPLETING THIS INVENTORY ***
APPENDIX G
POLYSOMNOGRAPHY DESCRIPTION FOR SUBJECTS
We ask that you report to the hospital approximately 
two hours before your normal bedtime. There you will find 
a comfortable bedroom setting in which to spend the night. 
Each subject will be provided with a private bedroom and 
bathroom to assure privacy. Subjects will provide their 
own sleeping attire, and should plan to bring these items 
with them to the hospital. Please refrain from napping or 
consumption of alcoholic beverages or medications during 
the day on which you are scheduled to participate in the 
sleep study. In addition, do not consume foods or 
beverages containing caffeine or other stimulants after 6 
pm on the evening of the polysomnogram.
During the hookup procedure small gold cups will be 
placed in various positions on your head, face, and legs. 
This is a painless and harmless procedure, using a paste 
that easily washes off. You will be asked to sleep in the 
bedroom with the electrodes attached to you. The 
experience of many years of such recordings indicates that 
individuals have no difficulty sleeping with these 
recording elements attached to their skin. We will be 
recording electrical activity of your brain, movement of 
your eyes, and activity of your sweat glands and muscles.
A research assistant in a nearby room will be 
watching a television monitor connected to a video camera 
in the room in which you are sleeping. The purpose of 
this camera is to determine the position in which you are 
sleeping during the night. The research assistant will 
also be monitoring the room over an intercom system. 
Therefore, you can be heard easily in the event that you 
should need assistance during the night.
You will be awakened for the day at 6:30 am.
Recording equipment will be removed and you will be asked 
to corrplete a brief questionnaire asking about how well 
you slept the night before. Your participation will then 
be complete, and you will be able to leave the lab at 
approximately 6:45.
I understand the procedures involved in 
polysomnography, and agree to participate in this portion 
of the research study. I will arrive at the Baton Rouge 
General Medical Center
at______________pm on the following date________________ .
Signature of Subject Signature of Research
Assistant
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INFORMED CONSENT FOR POLYSOMNOGRAPHY
I, _________________  _____ _ _______ , freely and
willingly consent to participate m  a research project 
investigating sleep patterns in individuals with high 
versus low trait anxiety. As a research subject, I will 
complete psychometric screening measures and participate 
in one night of polysomnography.
I understand that this procedure is non-invasive and 
are no foreseeable risks associated with polysomnography. 
I understand that the results of this study may 
potentially assist in the further understanding of the 
sleep disturbances which often accompany anxiety states.
I understand that I may chose to decline to 
participate in this study at any time without any penalty 
or jeopardizing, in any way, any future medical treatment 
in this institution. Finally, I understand that my 
privacy will be protected and my name will not be used in 
any manner whatsoever in subsequent use of the results of 
this study. I understand that results of both 
polysomnography and psychometric testing will remain 
strictly confidential; and that I will be assigned a 
subject number which will be used in subsequent data 
analysis in the place of my name.
I have read and thoroughly understand this consent 
form and acknowledge that I have been given a copy of the 
consent form for my own use.
Subj ect1 s Name Date
Experimenter Date
APPENDIX I 
POLYSOMNOGRAPHY HOOK-UP PROCEEDURES
Subjects were allowed to ask any questions prior to 
electrode placement. The subject then changed into his/her 
sleeping apparel and sat in a chair placed at bedside for 
electrode placement. Electrodes were placed on the 
subject's scalp, face and hand. All EEG, EMG, and EOG 
electrode placements were based on the system developed at 
Stanford University School of Medicine and described in 
Carskadon's widely used manual A Manual for Polysomnography 
(PSG) Technicians (Carskadon, 1980).
Electroencephalogram (EEG) electrode placements were 
based on a simplified version of the 10-20 system developed 
by the International Federation of Societies of 
Electroencephalography and Clinical Neurology (Carskadon, 
1980) . This system is based on measurements from four 
standard points on the head: (1) nasion (depression at 
bridge of the nose), (2) inion (the protrusion of bone in 
the back of the head), and (3) left and right pre-auricular 
points (notches just in front and above the lobes of the 
ears (Hassett, 1978). The following notations are used in 
designation of electrode placements: F (frontal), C
(central), P (parietal), T (temporal) , 0 (occipital), Fp 
(frontal pole), and z (midline) . In addition, odd 
subscripts refer to the left side of the skull and even
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subscripts refer to the right side of the head when 
referring the electrode placement sites.
The following procedures were used to determine exact 
electrode placement on individual subjects. The distance 
between the nasion and inion was be measured using a 
flexible tape. A grease pencil was used to mark the center 
point on the skull between these two reference points (Cz). 
Marks were also placed perpendicular to the tape at 
distance 10% up from the inion (Oz) and nasion (Fpz).
These marks served as landmarks for other measurements.
The distance between the left and right pre-auricular 
points was then measured by placing the tape along the 
first Cz mark. A mark was placed perpendicular to the tape 
at the center point on the skull. The intersection of the 
first and second mark indicated the precise location of Cz 
(the middle of the top of the head. Marks were also placed 
10% up from the left and right pre-auricular points (T3 and 
T4 respectively) . These marks also served as landmarks for 
other measurements.
The distance between T3 and Cz was measured by placing 
the tape on the transverse plane through Cz. A mark was 
then placed perpendicular to the tape at the center point 
(C3). This same series of measurements was repeated (using 
points T4 and Cz) in determining the location of C4. The 
measuring tape was then placed around the circumference of 
the head passing through Fpz, T3, Oz and T4. Marks were
placed perpendicular to the tape at distances of 5% of the 
circumference to the left and right of Fpz and Oz. These 
points represented Fpl, Fp2, 01 and 02 respectively. The 
second mark, delineating the exact location of C3, was made 
by placing the measuring tape from 01 to Fpl through the 
existing mark for C3. A mark was placed perpendicular to 
the tape at the center point, thus forming an intersection 
with the previous C3 mark which pinpoints the exact 
location of C3. The same procedure was used on the right 
side of the skull to determine the exact placement of C4. 
The second marks for 01 and 02 were made by continuing the 
mark from Oz to intersect with the original 01 and 02 
marks.
Grass electrodes (gold plated, 8mm diameter) were 
placed at the intersection of marks for Fpz, C3, C4, Cz,
01, and 02. The electrode of Fpz served as a ground; it 
was not referenced to another electrode and did not serve 
as a recording channel. The electrode for C3 was 
referenced to an electrode placed on the mastoid process 
behind the right ear (A2). The electrode for C4 was 
referenced to an electrode placed on the mastoid process 
behind the left ear (Al). The C3 and C4 electrodes, along 
with their respective reference points, served as backup 
recording channels for each other. The electrode for Cz 
was referenced to both Al and A2 electrodes. The 02 
electrode was referenced to the Cz electrode. The
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electrode at 01 served as a backup in case the 02 electrode 
lost contact with the scalp during the course of the 
recording. The signals from electrodes at C3, Cz, C4, 01, 
and 02 (along with their respective reference electrodes) 
were fed into a Grass Electroencephalograph Model 8-16 D, 
with the sensitivity set at 5 microvolts per mm and the 
high frequency and low frequency filters set at 35 Hz and 
.3 Hz respectively.
Continuous eye movement recordings (EOG's) were also 
made with Grass electrodes (gold plated, 8mm diameter) 
which were attached one centimeter above the right outer 
canthus (outer comer of the eye) and one centimeter below 
the left outer canthus. The electrodes for both the right 
eye (EOG-right) and left eye (EOG-left) were referenced to 
the electrode placed on the left mastoid process (Al) . 
Sensitivities for these recording channels were set at 15 
microvolts per mm. The high frequency filters were set at 
35 Hz and low frequency filter at .3 Hz.
Electromyogram (EMG) muscle potential recordings were 
also recorded continuously using Grass electrodes (gold 
plated, 8mm diameter) which were attached to muscle areas 
on (mental muscles) and beneath (submental muscles) the 
chin and on both legs (right and left anterior tibialis 
muscles) . Sensitivity for the channel recording 
mental/submental EMG was set at 2 microvolts per mm, with 
the high frequency filter set at 70 Hz and the low
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frequency filter set at 5 Hz. ENG recordings taken from 
the anterior tibialis muscles of each leg were taken from 
two electrode sites placed 4 cm apart on each leg. 
Sensitivities for these recordings were set at 7 microvolts 
per mm, the high frequency filter was also set to 70 Hz and 
the low frequency filter to 5 Hz for these channels.
Skin potential was used as a measure of electrodermal 
activity, and was recorded with Med Associates silver- 
silver chloride electrodes (20 mm diameter) taped to the 
palmar surface of the distal phalange of the ring finger of 
the right hand and to the medial surface at the elbow of 
the right arm. This channel was recorded using a 
sensitivity setting of 7 microvolts per mm, with the high 
frequency filter set to 15 Hz and the low frequency filter 
set to .1 Hz.
In addition, airflow was monitored via an oral/nasal 
thermistor in order to rule out the presence of sleep 
apnea. The sensitivity for this recording channel was set 
at 7 microvolts per mm and high and low frequency filters 
were set at 15 Hz and .1 Hz respectively.
All electrode sites were prepared by lightly abrading 
the skin surface with Omni Prep, a standard hypo-allergenic 
skin cleanser. Electrodes for EEG and chin EMG were 
affixed to the skin by placing a one-inch gauze square 
which has been soaked in collodion (a standard adhesive) 
over the electrode and drying the gauze using an air
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compressor with an electrode applicator attached. These 
electrodes were removed using collodion remover, a standard 
hypo-allergenic adhesive remover, in the morning.
Electrodes for EOG and leg EMG were taped to the skin. All 
electrodes were filled through a hole on their top surface 
with Beckman Electrode Electrolyte using a syringe with a 
blunt needle. Electrodes for skin potential were attached 
to the skin using a double sided adhesive collar, and were 
filled with Beckman Electrode Electrolyte prior to 
attachment to the skin.
After the electrodes were placed on the subject, they 
were attached to a terminal box. The inpedance was then 
checked by attaching the terminal box to an impedance meter 
which has been calibrated to 10 kilohms. The impedance of 
EEG, EMG, and EOG channels were checked to ensure that all 
impedance readings were below 10 kilohms. If the impedance 
is greater than 10 kilohms for any electrode, that 
electrode was removed from the subject, the site was 
cleaned again, and the electrode re-attached. Once all 
impedance readings are below 10 kilohms, the terminal box 
was connected to the Grass Electroencephalograph Model 8-16 
D. Paper speed for all recordings was 10 mm per second, at 
which one page of polygraph paper was recorded in 30 
seconds of electrophysiological activity (one epoch).
After the terminal box was connected to the 
electroencephalograph, recording channels were checked.
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The subject was then asked to move his/her eyes, bite down, 
move his/her legs, hold his/her breath for ten seconds, and 
to close his/her eyes and relax so that EEG, EMG and EOG 
channels could be checked. When all channels were 
functioning properly, the technician answered any questions 
which the subject had at this time. The lights were then 
turned off and the subject allowed to sleep.
APPENDIX J
SLEEP PROTOCOL MONTAGE
Montacre
Channel Sensitivity HFL (Hz) LLF (Hz)
Channels 1-4 1 5 uv/mm 35 .3 C3-A2
are EEG 2 5 uv/mm 35 .3 C4-A1
channels 3 5 uv/mm 35 .3 c z-a i/a :
4 5 uv/mm 35 .3 02-CZ
Chin EMG 5 2 uv/mm 70 5 F3-FZ
EOG Left 6 15 uv/mm 15 .1 Fpl-Al
EOG Right 7 15 uv/mm 15 .1 Fp2-A2
Oral/Nasal
Thermistor 8 7 uv/mm 15 .1 T3-T4
Skin
Response 9 7 uv/mm 15 .1 36-37
Leg EMG (R) 10 7 uv/mm 70 5 26-27
Leg EMG (L) 11 7 uv/mm 70 5 28-29
Paper speed is 10 mm/second
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APPENDIX K
DAILY SLEEP DIARY
NAME: _______________________ DATE:_________________
PLEASE RESPOND TO THE FOLLOWING QUESTIONS.
1. About what time did you first try to fall asleep last 
night? __________
2. Approximately how many minutes did it take you to fall 
asleep? _________
3. Please record the approximate times you awoke last 
night, and below that, how long it took you to get back to 
sleep.
min min m m  m m  m m
4. When did you awaken for the day this moming?_
5. How difficult was it for you to fall asleep last night?
1 2 3 4 5
Not Very Extremely
Difficult Difficult
6. How rested do you feel this morning?
1 2 3 4 5
Very Rested Poorly Rested
7. Rate the quality of last night's sleep.
1 2 3 4 5
Excellent Very Poor
8. What was your level of physical tension when you went 
to bed last night?
1 2 3 4 5
Extremely Extremely
Relaxed Tense
9. Rate your level of mental activity when you went to bed 
last night.
1 2 3 4 5
Very Quiet Very Active
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APPENDIX L 
MICRO-AROUSAL SCORING PROCEEDURES
Scoring of micro-arousals will follow the recent 
standardized guidelines described by Bonnet et al. (1992). 
A micro-arousal will be defined as an abrupt shift in EEG 
frequency, which may include theta, alpha, and/or 
frequencies greater than 16 Hz but not spindles, subject 
to the following rules and conditions: (1) Subjects must 
be asleep, defined as 10 continuous seconds or more of the 
indications of any stage of sleep before an arousal can be 
scored. Arousal scoring is independent of Rechtschaffen 
and Kales epoch scoring (i.e. an arousal can be scored in 
an epoch of recording which would be classifies as wake by 
Rechtschaffen and Kales criteria) . (2) A minimum of 10
continuous seconds of intervening sleep is necessary 
between independent arousals. (3) The EEG frequency shift 
must be 3 seconds or greater in duration to be scored as 
an arousal. (4) Arousals in NREM sleep may occur without 
concurrent increases in chin EMG amplitude. (5) Arousals 
in are scored in REM sleep only when accompanied by 
concurrent increases in chin EMG amplitude. (6) Arousals
cannot be scored based on changes in chin EMG amplitude 
alone. (7) Artifacts, K complexes, or delta waves are not 
scored as arousals unless accompanied by an EEG frequency 
shift of at least 3 seconds duration. If such activity
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precedes an EEG frequency shift, it is not included in 
reaching the 3-second duration criteria. When occurring 
within the EEG frequency shift, such artifacts are 
included in meeting duration criteria. (8) The occurrence 
of pen blocking artifact is considered an arousal only if 
an EEG arousal pattern is contiguous. In this event, the 
pen blocking artifact may be included in meeting the 
duration criteria. (9) Non-concurrent, but contiguous,
EEG and EMG changes which were individually less than 3 
seconds, but together were greater than 3 seconds in 
duration, are not scored as arousals. (10) Intrusion of 
alpha activity of less than 3 seconds into NREM sleep at a 
rate greater than one burst per 10 seconds is not scored 
as an EEG arousal. (11). Transitions from one stage of 
sleep to another are not sufficient of themselves to be 
scored as EEG arousals unless they meet the criteria 
previously outlined.
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